Product Detail Manual EP

User Manual: EP

Open the PDF directly: View PDF PDF.
Page Count: 41

EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 1
(1 March 2018)
EUROPEAN PATENT OFFICE (EPO)
AS
DESIGNATED (OR ELECTED) OFFICE
CONTENTS
THE ENTRY INTO THE NATIONAL PHASE SUMMARY
THE PROCEDURE IN THE NATIONAL PHASE
ANNEXES
Fees ............................................................... Annex EP.I
Entry into the European phase (EPO as designated or elected Office)
(EPO Form 1200) ................................................... Annex EP.II
Designation of inventor (EPO Form 1002) .................................. Annex EP.III
Authorisation (EPO Form 1003) .......................................... Annex EP.IV
General Authorisation (EPO Form 1004) ................................... Annex EP.V
List of abbreviations:
EPC: Convention on the Grant of European Patents (European Patent Convention)
Rfees: Rules relating to Fees (of the European Patent Office)
OJ EPO: Official Journal of the European Patent Office
Euro-PCT Guide (www.epo.org/applying/international.html)
EP
PCT Applicant’s Guide National Phase National Chapter EP
Page 3
(1 March 2018)
Designated
(or elected) Office
SUMMARY
EP
EUROPEAN PATENT OFFICE (EPO)
EP
Summary of requirements for entry into the national phase
Time limits applicable for entry into the
national phase:
Under PCT Article 22(3): 31 months from the priority date
Under PCT Article 39(1)(b): 31 months from the priority date
Translation of international application
required into:
English, French or German
Required contents of the translation for
entry into the national phase:
Under PCT Article 22: Description, claims (if amended, both as
originally filed and as amended, if the applicant wishes the
amendments to form the basis for the proceedings, together with any
statement under PCT Article 191), any text matter of drawings,
abstract
Under PCT Article 39(1): Description, claims, any text matter of
drawings (if any of those parts has been amended, both as originally
filed and as amended by the annexes to the international preliminary
report on patentability (Chapter II) and claims amended under PCT
Article 19, if the applicant wishes these amendments to form the
basis for the proceedings, together with any statement under PCT
Article 191), abstract
Is a copy of the international application
required?
No
National fee:
Currency: Euro (EUR)
Filing fee:2
where the form for entry into the European
phase (EPO Form 1200) is filed online: EUR 120
where the form for entry into the European
phase (EPO Form 1200) is not filed online: EUR 210
Additional fee for pages in excess of 35:
for the 36th and each subsequent page EUR 15
Designation fee for one or more EPO
Contracting States designated:3 EUR 585
Extension fee for each extension State
(extension of the European patent to Bosnia
and Herzegovina or Montenegro):3 EUR 102
Fee for validation of the European patent in:
Cambodia:3, 4 EUR 180
Morocco:3, 5 EUR 240
Republic of Moldova:3, 6 EUR 200
Tunisia:3, 7 EUR 180
[Continued on next page]
______________
1
Where the applicant furnishes only one translation of the international application, or any part of it, either as originally filed or as
amended, the Office will invite the applicant to furnish the missing translation within a reasonable time limit. If the translation of
the amended part or of the international application as initially filed is missing and is not furnished, the international application
will be considered withdrawn.
2
Must be paid within 31 months from the priority date. For claims fees see also paragraph EP.08 of National Chapter EP.
3
The designation, extension and validation fees are payable within 31 months from the priority date.
4
Validation of the European patent in Cambodia is only available for international applications filed on or after 1 March 2018.
See OJ EPO 2/2018, A16.
5
Validation of the European patent in Morocco is only available for international applications filed on or after 1 March 2015.
See OJ EPO 2/2015, A18-A20.
6
Validation of the European patent in the Republic of Moldova is only available for international applications filed on or after
1 November 2015. See OJ EPO 10/2015, A85.
7
Validation of the European patent in Tunisia is only available for international applications filed on or after 1 December 2017.
See OJ EPO 10/2017, A85.
EP
Page 4
PCT Applicant’s Guide National Phase National Chapter EP
(1 March 2018)
SUMMARY
Designated
(or elected) Office
SUMMARY
EP
EUROPEAN PATENT OFFICE (EPO)
[Continued]
EP
National fee (cont’d):
Claims fee:8
for the 16th and each subsequent claim
up to the limit of 50: EUR 235
for the 51st and each subsequent claim: EUR 585
Search fee:8
for (international) applications filed
before 1 July 2005: EUR 885
for (international) applications filed
on or after 1 July 2005: EUR 1,300
Fee for further processing:
in the event of late payment
of a fee: 50% of the relevant fee
other cases: EUR 255
Fee for late furnishing of a sequence listing:EUR 230
Examination fee:9
for (international) applications filed
before 1 July 2005: EUR 1,825
for (international) applications filed
on or after 1 July 2005 for which no
supplementary European search
report is drawn up: EUR 1,825
for all other (international) applications
filed on or after 1 July 2005: EUR 1,635
Renewal fee for the third year:10 EUR 470
Exemptions, reductions or refunds of
fees:11
No search fee is payable
where the international search report has been established by the
EPO;
where the international application has been filed before
1 July 2005 and the international search report has been
established by the Austrian Patent Office, the Spanish Patent and
Trademark Office or the Swedish Patent and Registration Office;
where the international application has been filed between
1 April 2005 and 30 June 2005 and the international search
report has been established by the Finnish Patent and
Registration Office (PRH).
The search fee is reduced
by 20% (international applications filed before 1 July 2005) or
by EUR 190 (international applications filed on or after
1 July 2005)
where the international search report has been established by the
Australian Patent Office, the Federal Service for Intellectual
Property (Rospatent) (Russian Federation), the Japan Patent Office,
the Korean Intellectual Property Office, the State Intellectual
Property Office of the People’s Republic of China or the United
States Patent and Trademark Office.
[Continued on next page]
______________
8
See footnote 2.
9
A request for examination must be made and the examination fee must be paid within the time limit applicable under PCT
Article 22 or 39(1) and EPC Rule 159(1).
10
This fee is due before the expiration of the month containing the second anniversary (24 months) of the international filing date; it
is due within 31 months from the priority date if that 31-month time limit expires later.
11
See OJ EPO 3/2006, pages 189 and 192, 12/2007, page 692, 1/2008, page 12 and 2/2009, page 96 et seq., 5/2010, page 338 et seq.
and 12/2011, page 616 et seq.
EP
PCT Applicant’s Guide National Phase National Chapter EP
Page 5
(1 March 2018)
Designated
(or elected) Office
SUMMARY
EP
EUROPEAN PATENT OFFICE (EPO)
[Continued]
EP
Exemptions, reductions or refunds of
fees (cont’d):12
The search fee is reduced
by EUR 1,11013 for international applications for which the
international search report or a supplementary international search
report has been established by the Austrian Patent Office, or in
accordance with the Protocol on Centralisation by the Finnish Patent
and Registration Office (PRH), the Nordic Patent Institute, the
Spanish Patent and Trademark Office, the Swedish Patent and
Registration Office, the Turkish Patent and Trademark Office
(Turkpatent) or the Visegrad Patent Institute.
The search fee is refunded fully or in part where the supplementary
European search report is based on an earlier search report prepared
by the Office.
The examination fee is reduced by 50% where the international
preliminary report on patentability (Chapter II) has been established
by the EPO.14
Furthermore, in certain cases the examination fee is reduced by 30%
for language reasons.14
Special requirements of the Office
(PCT Rule 51bis):15
Name and address of the inventor if they have not been furnished in
the “Request” part of the international application or in a declaration
in accordance with PCT Rule 4.17(i)
Address, nationality and residence of the applicant if they have not
been furnished in the Request part of the international application
Appointment of an agent if the applicant has neither a residence nor
his principal place of business within the territory of one of the
Contracting States of the European Patent Convention
Furnishing, where applicable, of a nucleotide and/or amino acid
sequence listing in electronic form
Who can act as agent?
Any professional representative entered on the relevant list
maintained by the EPO (the directory of professional representatives
can be consulted on the EPO website)16
Any legal practitioner qualified to practice in patent matters in one
of the States party to the European Patent Convention and who has
his place of business in that State
Does the Office accept requests for
restoration of the right of priority
(PCT Rule 49ter.2)?
Yes, the Office applies the “due care” criterion to such requests
______________
12
See footnote 11 and OJ EPO 3/2013, page 153 et seq.
13
See the Decisions of the EPO’s Administrative Council dated 16 December 2015 (CA/D 8/15) and 28 June 2017 (CA/D 9/17).
14
See also paragraph EP.14 of National Chapter EP and OJ EPO 2/2014, A23.
15
If not already complied with within the time limit applicable under PCT Article 22 or 39(1) (31 months from the priority date), the
Office will invite the applicant to comply with the requirement within two months. In respect of nucleotide and/or amino acid
sequence listings, see also OJ EPO 6/2011, page 372 and OJ EPO 11/2013, page 542.
16
See www.epo.org/applying/online-services/representatives.html
EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 7
(1 March 2018)
THE PROCEDURE IN THE NATIONAL PHASE
Detailed information on the procedure before the EPO as designated Office and as elected
Office can also be found in the Euro-PCT Guide (“PCT procedure before the EPO”), to be
ordered from the EPO Customer Service Centre and available on the EPO website
www.epo.org/applying/international.html
Euro-PCT Guide, 420
et seq.
EP.01 FORM FOR ENTERING THE NATIONAL PHASE. The EPO has available a
special form for entering the national phase (EPO Form 1200see Annex EP.III).
The EPO strongly recommends that applicants use the latest version of this form which
contains detailed explanatory notes. The form is also available on the EPO’s website:
www.epo.org/applying/forms-fees/forms.html. The form may be filed electronically (see
OJ EPO 2015, A91). It is also possible to file EPO Form 1200 online via the EPO case
management system and the EPO web-form filing service (see OJ EPO 2014, A98 and
OJ EPO 2015, A27).
EPC Art. 14
153(4)
Euro-PCT Guide, 418
419
EP.02 LANGUAGE OF PROCEEDINGS. The language of proceedings is one of the
EPO official languages (English, French or German). If the international application has been
published in one of those languages, this language is the language of proceedings; if not, the
language of the translation which must be submitted upon entry into the European phase will be
the language of the proceedings. The language of proceedings cannot be changed
subsequently.
EPC Rule 3(1), 3(2)
Euro-PCT Guide, 512
In written proceedings, the applicant may use any official language of the EPO. However,
amendments (see paragraph EP.18) to the application itself must be filed in the language of the
proceedings.
PCT Art. 19(1)
PCT Rules 49.3
70.16
74(1)
Euro-PCT Guide, 517-
521
EP.03 TRANSLATION OF THE APPLICATION. In addition to those elements of the
translation which must be furnished within the time limit of 31 months from the priority date
(the description, the claims and any text in the drawings as originally filed and the abstract as
published), the following elements should also be included:
if the EPO acts as designated Office:
any amendments made to the claims under PCT Article 19 in the form of a
translation of the complete set of claims furnished in replacement of all claims originally filed
only if the applicant wishes such amendments to form the basis of further proceedings. The
amendments must be submitted together with, if submitted to the International Bureau, the
statement under PCT Article 19(1) explaining the amendments and, in every case, the
accompanying letter under PCT Rule 46.5(b) in an official language of the EPO. If a
translation of the complete set of claims submitted under PCT Article 19 is not furnished or not
accompanied by a translation of, if submitted to the International Bureau, the statement under
PCT Article 19(1) and, in every case, the accompanying letter under PCT Rule 46.5(b), the
amendments under PCT Article 19 will be disregarded for the further proceedings. If only the
statement under PCT Article 19(1) is not available in an official language, only that document
will be disregarded;
any indication under PCT Rule 13bis.3 and 13bis.4, i.e., separately furnished
reference to deposited biological material;
any nucleotide and amino acid sequence listing under PCT Rule 5.2(a), unless the
text in the sequence listing is available to the EPO in English;
any request for rectification referred to in PCT Rule 91.3(d) as published in
accordance with PCT Rule 48.2(a)(vii).
if the EPO acts as elected Office:
translation of any annexes to the international preliminary report on patentability
(Chapter II), i.e. regardless of whether protection is sought for the same version of the
application documents as was the subject of that report. If any amendments under PCT Article
19 are annexed to the IPRP (Chapter II), a translation of those amendments must also always be
filed.
EP
Page 8 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
If the applicant wishes the amendments to the claims made before the IB under PCT Article 19
to form the basis of the procedure before the EPO as elected Office, and these amendments are
not annexed to the IPRP (Chapter II) (for instance because they were considered reversed by an
amendment under PCT Article 34), then these amendments must also be furnished in translated
form, as otherwise they will be disregarded for the further proceedings. Any statement under
PCT Article 19(1) and, in every case, the letter under Rule PCT 46.5(b) must also be furnished
in an official language of the EPO. If only the statement under PCT Article 19(1) is not
available in an official language, only that document will be disregarded.
If the translation of all annexes is not filed in due time, the applicant is invited to furnish the
missing translation within two months of notification of a communication. If the applicant fails
to comply, the Euro-PCT application is deemed to be withdrawn. The applicant may request
further processing (or re-establishment of rights under PCT Rule 49.6 if the application is
deemed withdrawn because the translation was not filed in due time. However, the fee is
higher and stricter requirements apply. Therefore, this remedy has only advantages if the
period for requesting further processing has already expired).
EP.04 TRANSLATION (CORRECTION). Errors in the translation of the international
application can be corrected with reference to the text of the international application as filed
(see National Phase, paragraphs 6.002 and 6.003).
RFees Art. 5
EP.05 FEES (MANNER OF PAYMENT). The manner of payment of the fees indicated
in the Summary and in this Chapter is outlined in Annex EP.I. Payments via a deposit account
held with the EPO are only accepted if made online, i.e. in an electronically processable format
(XML), using, e.g. the electronic EPO filing forms or the Online Fee Payment in Online
services. This also applies to automatic debit orders. For more details, see Extract from the
Arrangements for deposit accounts (ADA) and their annexes in Annex EP.I and the
Supplementary publication 5 to OJ EPO 2017.
PCT Art. 22(1), 39(1)
EPC Art. 78(2)
EPC Rule 159(1)(c)
165
RFees Art. 2(1).1
OJ EPO 2009, 118
Euro-PCT Guide, 534-
536
661
EP.05a FILING FEE. Within the 31-month time limit the European filing fee must be paid.
This fee is composed of a basic fee and an additional fee which is due for the 36th and each
subsequent page of the application. The additional fee is referred to as the “page fee”. The
basic fee is reduced where EPO Form 1200 is filed online, via the EPO case management
system or the EPO web-form filing service. If the basic filing fee and/or, where applicable, the
page fee, is not paid in full in due time, the application will be deemed withdrawn. In addition,
the Euro-PCT application will not be considered as comprised in the state of the art under
EPC Article 54(3).
EPC Rule 38(2)
RFees Art. 2(1).1a
OJ EPO 2009, 338
Euro-PCT Guide, 537-
544
EP.05b PAGE FEE. As a general rule, the page fee is based on the international application
as published, regardless of the language of publication. The pages of the description, claims
and drawings are counted, plus one page in total for any pages with the bibliographic data and
the abstract. Amended claims under PCT Article 19 and/or PCT Article 34 are also considered
part of the international publication and must be taken into account unless the applicant has
indicated that the procedure in the European phase is not to be based on them. If (parts of) the
description and/or claims are amended on entry into the European phase, the amended pages of
the description and the amended set of claims replace the equivalent pages of the international
application as published and, consequently, form then the basis for calculating the page fee.
However, the calculation of the page fee cannot be based on pages of the description or of the
claims drafted partly in an official language of the EPO and partly in another language. Thus,
special rules for calculating the page fee apply if the international application was not published
in one of the official languages of the EPO and amendments are filed upon entry into the
European phase. Detailed information regarding the correct calculation of the page fee in such
case is provided in OJ EPO 2009, 338 and in the Guidelines for Examination in the EPO, A-III,
13.2. Completion of section 6 of EPO Form 1200 and the related table serves applicants to
clearly indicate to the EPO the documents on which the further proceedings are to be based and
to correctly compute the page fee.
Pages with amendments filed after expiry of the 31-month time limit are not taken into account
in calculating the page fee. Furthermore, page fees will not be refunded if the number of pages
is reduced during the proceedings before the EPO.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 9
(1 March 2018)
EPC Art. 79(2)
EPC Rules 39(1)
159(1)(d)
160
RFees Art. 2 No. 3
Euro-PCT Guide, 549
et seq.
EP.06 EUROPEAN DESIGNATION FEE. A (flat) designation fee must be paid within
six months from the publication by the International Bureau of the international search report or
before the expiration of the time limit applicable under PCT Articles 22(3) and 39(1)(b)
and EPC Rule 159 (31 months from the filing date or, if priority has been claimed, the earliest
priority date), whichever time limit expires later. If the designation fee is not paid in due time,
the Euro-PCT application will be deemed withdrawn.
Euro-PCT Guide, 556
et seq.
OJ EPO 2009, 603
OJ EPO 2015, A18-20
A84
A85
OJ EPO 2016, A5
A67
OJ EPO 2017, A85
OJ EPO 2018, A16
EP.07 EXTENSION/VALIDATION. International applications entering into the national
phase at the EPO (European phase) can be extended to or validated in certain States which
have concluded an Extension or Validation Agreement to that effect with the European Patent
Organisation (they are indicated in the Summary), provided the Extension/Validation
Agreement with the EPO was in force at the international filing date, the State concerned was
designated for a national patent in the international application and the respective
extension/validation fees have been paid, the amount of which is indicated in Annex EP.I. For
payment of the extension/validation fee, the provisions for payment of the European
designation fees apply mutatis mutandis. The request for extension/validation for a state is
deemed withdrawn if the extension/validation fee is not paid to the EPO within the time limit
laid down in the EPC for the payment of the designation fee (EPC Rule 159(1)(d)). If the
designation fee was paid but none of the extension/validation fees, no communication pointing
out the failure to observe the time limit for payment of the extension/validation fees is issued.
However, the applicant may still pay an extension/validation fee after expiry of the (basic) time
limit for payment of the designation fee and the extension/validation fees with a 50% surcharge
within a grace period of two months as from expiry of the basic time limit. Furthermore, where
in the absence of payment of the designation fee in due time further processing can be
requested in respect of the designation fee, the applicant may within two months from
notification of the communication of the loss of rights also pay the extension/validation fee(s)
with a 50% surcharge (see Guidelines for Examination in the EPO, A-III, 12.2). When an
extension State accedes to the EPC, the Extension Agreement remains applicable to
international applications filed prior to the date of accession.
EPC Rule 162
Euro-PCT Guide, 602
et seq.
EP.08 CLAIMS FEES. If the application documents on which the European grant
procedure is to be based contain more than fifteen claims, a claims fee is payable within the
31-month period in respect of the sixteenth and each subsequent claim. A higher claims fee is
payable in respect of the 51st and each subsequent claim. The claims fees must be calculated on
the basis of the number of claims specified to form the basis for the further proceedings on
entry into the national phase (that is, where amendments have been filed, the claims as
amended under PCT Article 19 or 34(2) or the claims as submitted by the applicant under
PCT Article 28 or 41 upon entering the national phase), unless the applicant uses the
opportunity to amend the claims in response to the communication pursuant to EPC Rules 161
and 162 referred to in paragraph EP.18, the claims thus amended being then used as the basis
for calculation of the claims fee and for the further proceedings. Where the applicant fails to
pay the correct amount of the claims fees within the 31-month time limit, the EPO will invite
him to pay the missing amount within the non-extendable six-month time limit set in the
communication under EPC Rules 161 and 162. Where the number of claims changes as a
consequence of a later (further) amendment filed in response to the communication pursuant to
Rules 161 and 162, that number is to be used as the basis for calculating the amount of the
claims fees to be paid. Where a claim fee is not paid in due time, a noting of loss of rights
(EPC Rule 112(1)) is issued, giving the applicant the opportunity to request further processing
(EPC Article 121) by paying the missing claims fee(s) together with the applicable fee for
further processing within a period of two months from notification of the communication. If
not paid within that period, the claim(s) concerned shall be deemed to be abandoned. Features
of a claim deemed to have been abandoned and which are not otherwise to be found in the
description or drawings cannot subsequently be reintroduced into the application and, in
particular, the claims.
EPC Rule 163(1), (6)
Euro-PCT Guide, 608-
610
EP.09 DESIGNATION OF THE INVENTOR. For details, see the form for such
designation in Annex EP.IV. Legalization is not required. For time limits, see the Summary.
EP
Page 10 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
EPC Art. 133
134
EPC Rules 152
163(5), (6)
OJ EPO 2007, Special
Edition No. 3,
page 128 et seq.
Euro-PCT Guide, 459
et seq.
EP.10 APPOINTMENT OF AN AGENT AND POWER OF ATTORNEY. Natural and
legal persons having either their residence or their principal place of business within the
territory of one of the EPC contracting states may act on their own behalf in proceedings before
the EPO (EPC Article 133(1)). Natural and legal persons not having either a residence or their
principal place of business within the territory of one of the EPC contracting states must be
represented by a professional representative and act through him in all proceedings established
by the EPC (see the Summary, “Who can act as agent?”). In case of failure to appoint the
required professional representative, the applicant will be invited by the EPO to do so within
two months. If the deficiency is not corrected in due time, the application is refused.
Nevertheless, the applicant may act on his own behalf within the 31-month time limit
applicable under PCT Articles 22(3) and 39(1)(b) and EPC Rule 159(1). Under no
circumstances, however, may the applicant act through his agent appointed during the
international phase if the latter is not an agent entitled to practice before the EPO. Payments
can be made by anybody. A power of attorney (“Authorisation” or “General Authorisation”,
see samples given in Annexes EP.V and EP.VI, respectively), generally, need not be filed by an
agent who is a professional representative entered on the list maintained by the EPO. It is,
however, necessary that he informs the EPO of his appointment. This applies even if the
professional representative was appointed for the international phase, unless he was at the same
time also explicitly appointed for the European phase before the EPO acting as Receiving
Office. Legal practitioners entitled to practice before the EPO and employees representing an
applicant under EPC Article 133(3) who are not professional representatives must always file a
signed authorization or a reference to a general authorization already on file (for details, see the
Decision of the President of the EPO dated 12 July 2007 on the filing of authorizations,
OJ EPO 2007, Special edition No. 3, 128 et seq.). Only where the EPO acted as receiving
Office and the authorization expressly empowered the legal practitioner or employee to act
before the EPO in the national phase, is a new authorization not required. In the cases where a
power of attorney is required, the EPO will invite the applicant or agent to file it within a
period to be specified. If the authorization is not filed in due time, any procedural steps taken
by the agent will be deemed not to have been taken.
EPC Art. 86(1)
and (2)
EPC Rules 51
159(1)(g)
RFees Art. 2 No. 4, 5
Euro-PCT Guide, 599-
601
EP.11 RENEWAL FEES. They are payable for the third and each subsequent year
following the international filing date. Payment must be made before the expiration of the
month containing the anniversary of the international filing date. Payment can then still be
made, together with a 50% surcharge for late payment, before the expiration of the sixth month
after the month containing the anniversary of the international filing date. It is to be noted that
a renewal fee which is due within the 31-month time limit applicable under PCT Articles 22(3)
and 39(1)(b) can be paid without surcharge up to the expiration of the 31-month time limit.
The renewal fee can still validly be paid within six months after the expiration of the 31-month
time limit, subject to the payment of the 50% surcharge. If the renewal fee is not paid within
the six-month period, the application is deemed to be withdrawn. The failure to meet the time
limit for paying the renewal fee with surcharge may be remedied by filing a request for
re-establishment of rights (EPC Article 122, EPC Rule 136). The amounts of the renewal fees
are indicated in Annex EP.I. For the calculation of aggregate time limits, see OJ EPO 1993,
229, point II-3. Renewal fees may not be paid more than three months before they fall due.
EPC Art. 94
Euro-PCT Guide, 587-
589
EP.12 REQUEST FOR EXAMINATION. A European patent will be granted only if the
substantive examination of the application shows it to meet the requirements of the EPC.
Examination will only start upon explicit request. The request may be made by using the form
referred to in paragraph EP.01 (see pre-crossed box 4.1 of EPO Form 1200, Annex EP.III).
The request for examination is not deemed to be filed until after the examination fee has been
paid.
EPC Art. 94(2)
EPC Rule 159(1)(f)
Euro-PCT Guide, 590
EP.13 TIME LIMIT FOR REQUESTING EXAMINATION. Examination must be
requested within six months from the publication by the International Bureau of the
international search report or before the expiration of the time limit applicable under PCT
Articles 22(3) and 39(1)(b) and EPC Rule 159(1) (31 months from the filing date or, if priority
has been claimed, from the earliest priority date), whichever time limit expires later.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 11
(1 March 2018)
EPC Art. 94(1)
RFees Art. 14(2)
EP.14 FEE FOR EXAMINATION. The request for examination is only effective if the
examination fee has been paid. That fee must therefore be paid within the time limits set out in
paragraph EP.13. The amount of the said fee is indicated in Annex EP.I.
Euro-PCT Guide, 595
(i) It is reduced by 50% where an international preliminary report on patentability
(Chapter II) has been established by the EPO. If the report was established on certain parts of
the international application, the reduction is allowed only if examination is to be performed on
subject matter covered by the report.
EPC Art. 14(1)
EPC Rule 6(3)-(6)
RFees Art. 14(1)
Euro-PCT Guide, 594
OJ EPO 2014, A4, A23
(ii) Furthermore, a 30% reduction in the examination fee is available to SMEs, natural
persons, non-profit organizations, universities or public research organizations having their
residence or principal place of business in a EPC contracting state with an official language
other than English, French or German if they file the request for examination in an official
language of that state (“admissible non-EPO language”) and declare themselves to be entitled
to do so (EPC Rule 6(6)). Since the request for examination is only effective if the examination
fee has been paid, the request for examination in an admissible non-EPO language may still be
filed up until the examination fee is paid. If the request for examination in an admissible non-
EPO language is filed subsequently, it must be accompanied by a translation of the request for
examination in the procedural language. See also Annex EP.III, page 2, box 4.
RFees Art. 11
Euro-PCT Guide, 596
OJ EPO 2013, 153
(iii) If the conditions for both reductions are fulfilled, the examination fee is first
reduced by 50%. The 30% reduction is applied to the resulting total and not to the full fee.
Therefore, the total reduction in relation to the full fee is 65%.
RFees Art. 11(a), (b)
Euro-PCT Guide, 580-
581
OJ EPO 2016, A48, A49
The examination fee is refunded in full if the application is withdrawn, refused or deemed to be
withdrawn before substantive examination has begun. Fifty percent of the examination fee is
refunded if the application is withdrawn, refused or deemed to be withdrawn after the
examining division has begun but before expiry of the time limit for replying to the first
invitation under Article 94(3) EPC issued by the examining division, or if no such invitation
has been issued, before the date of the communication under Rule 71(3) EPC.
EPC Art. 121
EPC Rules 135
160
Euro-PCT Guide, 521
545-
548
553-
555
585-
586
597-
598
EP.15 CONSEQUENCES OF NON-FULFILMENT OF CERTAIN
REQUIREMENTS. EPC Rule 160 provides that if either the translation of the international
application or the request for examination is not filed in due time or if the filing fee, including
any additional fee for pages exceeding 35, the search fee, the examination fee or the
designation fee is not paid in due time, the European patent application is deemed withdrawn.
In these circumstances, the applicant will be informed of the deemed withdrawal and
EPC Rule 112(2) shall apply. However, the loss of rights shall be deemed not to have occurred
if, within two months of the EPO notification, further processing is requested by payment of the
respective fee(s) for further processing and the omitted act is completed.
If the applicant neither filed the request for examination nor paid the examination fee in due
time, further processing must be requested in respect of both omissions, i.e. in respect of filing
the request for examination and payment of the examination fee. It follows that the applicant
must file the request for examination and pay the examination fee itself together with two fees
for further processing: a flat fee for further processing in respect of the request for examination
and 50% of the examination fee.
EPC Art. 153(7)
EPC Rules 70
70a
161
Euro-PCT Guide, 569
et seq.
EP.16a SUPPLEMENTARY EUROPEAN SEARCH. As a rule, a supplementary
European search must be performed for each international application entering the European
phase and a search fee must be paid.
The supplementary European search will be based on the last set of (amended) claims available
to the EPO on the date of expiry of the time limit set under EPC Rule 161(2). Thus, any
amendment to the claims which has been filed up to that date will be taken into account (see
paragraph EP.18).
OJ EPO 2015, A94
Where the request for examination was filed before transmittal of the supplementary European
search report, which is usually the case, the EPO invites the applicant, after transmittal of the
supplementary European search report, to indicate whether he wishes to proceed further with
the application before the EPO. The applicant may waive the right to receive such
communication by informing the EPO thereof in due time.
EP
Page 12 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
If the applicant does not wish to proceed further, he may withdraw the application
or he may simply refrain from answering the invitation within the time limit fixed in it and the
application is deemed to be withdrawn. If the applicant wishes to proceed further, he must
notify the EPO accordingly. He may, at the same time, respond to the supplementary European
search report by filing amendments and/or comments on his application. The applicant is
required to reply to a search opinion within the time limit set by the EPO in its communication
under EPC Rule 70a(2) if the EPO has issued a negative written opinion (see Guidelines for
Examination in the EPO, B-XI, 8 and EP.18).
No supplementary European search performed:
Euro-PCT Guide, 574-
576
Dispensation applies and no search fee is to be paid if the international search report (or
supplementary international search report)1 was established by the EPO. In this case the
applicant will be invited to comment on the written opinion of the ISA or on the IPRP
(Chapter II), or on the supplementary international search report and to correct, if appropriate,
any deficiencies noted therein and to amend the application within six months2 from
notification of the invitation (EPC Rule 161(1)); see Guidelines for Examination in the EPO,
E-IX, 3.2 for more details.
Euro-PCT Guide, 582-
583
OJ EPO 2016, A2, A20
EP.16b SEARCH FEE. If a supplementary European search report is to be established, the
search fee must be paid within the 31-month time limit, and may be reduced as follows:
(i) by EUR 190 where the international search report was drawn up by the following
ISAs: the United States Patent and Trademark Office (USPTO), the Japan Patent Office (JPO),
the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the
People’s Republic of China (SIPO), the Federal Service for Intellectual Property (Rospatent)
(Russian Federation) or the Australian Patent Office;
OJ EPO 2017, A57
(ii) by EUR 1,110 where the international search report was drawn up by the
Austrian Patent Office, the Finnish Patent and Registration Office, the Nordic Patent Institute,
the Spanish Patent and Trademark Office, the Swedish Patent and Registration Office, the
Turkish Patent and Trademark Office (Turkpatent) or the Visegrad Patent Institute. This
reduction also applies when a supplementary international search was established by the
Austrian Patent Office, the Finnish Patent and Registration Office, the Nordic Patent Institute,
the Swedish Patent and Registration Office, the Turkish Patent and Trademark Office
(Turkpatent) or the Visegrad Patent Institute.
OJ EPO 2014, A29
Euro-PCT Guide, 584
If the application claims the priority of an earlier application for which a search was carried out
by the EPO, (a part of) the fee paid for the supplementary European search may be refunded.
The level of any refund depends on the type of the earlier search and the extent to which the
EPO benefits from the earlier search report when carrying out the supplementary search.
EPC Rules 30
163(3)
Euro-PCT Guide, 527-
533
OJ EPO 11/2013, 542
EP.17 NUCLEOTIDE AND AMINO ACID SEQUENCES. If a Standard-compliant
sequence listing in TXT format is contained in the international application under
PCT Rule 5.2, furnished to the EPO acting as ISA/SISA or IPEA under PCT Rule 13ter.1(a) or
made accessible to the EPO by other means, the applicant does not have to submit the
Standard-compliant sequence listing again in TXT format on entry into the regional phase
before the EPO as designated or elected Office.
Where, however, a Standard-compliant sequence listing in TXT format is not available to the
EPO on the expiry of the period under Rule 159(1) EPC, the applicant will be invited to file a
Standard-compliant sequence listing in TXT format within a non-extendable period of two
months from the invitation and to pay the late furnishing fee. EPC Rule 30(2) and (3) and
Article 1 of the Decision of the President of the European Patent Office dated 28 April 2011 on
the filing of sequence listings (OJ EPO 6/2011, 372) are to be applied accordingly (see
EPC Rule 163(3) in conjunction with Article 5 of the above-mentioned decision of the
President).
1
Applicable as from 1 July 2010 (see OJ EPO 12/2009, 594).
2
Applicable as from 1 May 2011 (see OJ EPO 12/2010, 634).
EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 13
(1 March 2018)
If any deficiencies are not remedied in due time after such an invitation this also applies to the
payment of the late furnishing fee the application will be refused (EPC Rule 30(3)). The
applicant may request further processing of the application under EPC Article 121 EPC (see
also Notice from the European Patent Office dated 18 October 2013 concerning the filing of
sequence listings, OJ EPO 11/2013, 542 et seq.).
Furthermore, the applicant must enclose, together with the late filed sequence listing in TXT
format, a declaration to the effect that the sequence listing does not extend beyond the content
of the application as originally filed (see EPO Form 1200, Section 9.2). The filing of the
sequence listing on paper / in PDF format is not required. However, if the sequence listing is
also filed on paper / in PDF format, the applicant has to submit a statement that the sequence
listing in electronic form and on paper or in PDF format are identical.
EPC Rule 161(1), (2)
OJ EPO 2010, 634
Euro-PCT Guide, 483-
508
EP.18 AMENDMENT OF THE APPLICATION; TIME LIMITS. For the purpose of
the procedure before the EPO as designated/elected Office the applicant may always file
(voluntary) amendments within the 31-month time limit, and if he subsequently changes his
mind he may file (further) amendments until expiry of the time limit set in the combined
communication under EPC Rules 161 and 162. The applicant may also be required to file
(mandatory) amendments to and/or comments on the application within the time limit set in the
communication under EPC Rules 161 and 162. Whether or not a response is mandatory is
clearly stated in the communication, its wording thus differing depending on the case
(EPO Forms 1226AA, 1226BB or 1226CC).
The communication under EPC Rules 161 and 162 is issued for each application promptly once
the application has entered the European phase and on condition that the ISR is available to
the EPO. This means that it is also issued if the applicant has already filed, with Form 1200 or
thereafter, amendments and/or comments to form the basis for the procedure in the European
phase. Pursuant to EPC Rules 161 and 162 the time limit set in the communication is
six months. This time limit cannot be extended.
Euro-PCT Guide, 442
489-
491
OJ EPO 2015, A94
In order to accelerate the grant procedure the applicant can waive his right to the Rule 161/162
communication by crossing the box in Section 12.2, first checkbox, of EPO Form 1200. The
waiver will only be effective if any claims fees due for the set of claims indicated as the basis
for the procedure in the European phase have been paid and any mandatory substantive
response to the WO-ISA / the IPRP (Chapter II) / the SISR, established by the EPO, was filed
on entry into the European phase.
EPC Rule 70a(2)
70a(3)
137(3)
Euro-PCT Guide, 493
503
After expiry of the six-month time limit further possibilities for amending the application are
limited. If no supplementary European search is carried out, it is at the discretion of the
examining division to allow amendments. If a supplementary European search is carried out,
the applicant always has one further opportunity to submit amendments upon receipt of the
report. Thus, after issuance of the supplementary European search report the applicant may,
first of all, comment on both the report and the search opinion and file (voluntary) amendments
to the description, claims and drawings within the period specified in the communication under
EPC Rule 70a(2) for indicating whether he wishes to proceed further with the application.
Secondly, if any deficiencies are noted in the search opinion, the applicant will be required
under EPC Rule 70a(2) to respond to the objections made. The application will be deemed
withdrawn if the applicant does not submit a substantive reply to the communication under
EPC Rule 70a(2) (“mandatory response”). The loss of rights can be remedied by requesting
further processing. Amendments made thereafter require the consent of the examining division.
EPC Art. 123(2)
Amendments may under no circumstances go beyond the disclosure in the international
application as filed.
EPC Rule 137(4)
Whenever amendments are filed, the applicant must identify them and indicate their basis in the
application as filed. If he fails to do so, the examining division may issue a communication
requesting correction of the omission within a non-extendable time limit of one month. If the
deficiency is not remedied in due time, the application will be deemed withdrawn under
EPC Art. 94(4). The loss of rights can be remedied by requesting further processing.
EPC Art. 97(1)
EPC Rule 71(3)-(6)
EP.19 GRANTING OF THE EUROPEAN PATENT. Prior to the decision to grant the
European patent, the applicant will receive a communication containing both the text in which
the Examining Division intends to grant the European patent and an invitation to pay the grant
and printing fees and supply a translation of the claims in the two other official languages of
EP
Page 14 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
the EPO. Performance of these acts implies approval of the text.3 If applicable, the
communication will also include an invitation to pay additional claims fees.
EPC Rule 71(3)
EP.20 FEE FOR GRANT, INCLUDING FEE FOR PUBLISHING AND CLAIMS
FEE. The amounts of the fees are indicated in Annex EP.I. They must be paid within four
months from the communication pursuant to EPC Rule 71(3) referred to in paragraph EP.19.
EPC Rule 71(3)
EP.21 TRANSLATION OF CLAIMS. Within the same period, the claims must be
translated into the two official languages of the EPO which are not the language of proceedings
(see paragraphs EP.02 and EP.19).
PCT Art. 23(2)
40(2)
EPC Rule 159(1)
Euro-PCT Guide, 427-
440
EP.22 EARLY PROCESSING OF NATIONAL PHASE. If the applicant wishes the
processing and the examination of his application to start earlier than the expiration of the time
limit applicable under PCT Article 22(3) or 39(1)(b), he must file an express request for early
processing. The request can be made by ticking the checkbox in section 12.1 of EPO
Form 1200. Moreover, the applicant must fulfill the requirements for entry into the European
phase as if the 31-month time limit provided for in EPC Rule 159(1) expired on the date he
requests early processing (see OJ EPO No. 3/2013, 156 et seq.).
PCT Art. 25
PCT Rule 51
82bis
EPC Rule 159(2)
Euro-PCT Guide, 637-
639
EP.23 REVIEW UNDER ARTICLE 25 OF THE PCT. The applicable procedure is
outlined in paragraphs 6.018 to 6.021 of the National Phase. At the request of the applicant,
the EPO may review whether a refusal by the receiving Office to accord a filing date, or a
declaration on the part of the receiving Office that a Euro-PCT application or the designation of
a state is considered withdrawn, or a finding by the International Bureau under PCT
Article 12(3) is the result of an error or omission on the part of the authority concerned, in
which case the Euro-PCT application can proceed as a European application.
To obtain such a review by the EPO as designated/elected Office, applicants must, within the
two-month time limit under PCT Rule 51.1, request the International Bureau under
PCT Art. 25(1) to send copies of documents in the files promptly to the EPO as designated
Office. Furthermore, the filing fee under EPC Rule 159(1)(c) must be paid and, where
required, a translation of the Euro-PCT application furnished within the same two-month time
limit (PCT Rule 51.3).
Applicants are recommended to undertake the remaining steps for entry into the European
phase under EPC Rule 159(1) at the same time.
EPC Art. 106
108
If, upon review under PCT Article 25, the EPO denies an error or omission on the part of the
receiving Office or the International Bureau, a notice of appeal against this decision may be
lodged within two months from the date of receipt of the decision. Within the same two-month
time limit, a fee for appeal must be paid (for the amount, see Annex EP.I). Within four months
from the date of receipt of the decision, grounds substantiating the notice of appeal must be
filed. The Board of Appeal will then decide on the appeal.
PCT Art. 24(2)
48(2)
PCT Rule 82bis
Euro-PCT Guide, 640
EP.24 EXCUSE OF DELAYS IN MEETING TIME LIMITS. Reference is made to
paragraphs 6.022 to 6.028 of the National Phase and to paragraph EP.15.
EPC Art. 121
EPC Rule 135
EP.25 FURTHER PROCESSING. Further processing of the application may be
requested where the applicant has missed a time limit during the international or the national
phase in respect of which further processing is not ruled out under Rule 135(2). If the request
is granted, this has the effect that the legal consequence of the failure to observe the time limit
is deemed not to have ensued. It must be made by completing the omitted act(s), as applicable,
and payment of the fee(s) for further processing, the amount of which is indicated in
Annex EP.I, within two months of the notification of the noting of loss of rights
(EPC Rule 112(1)). The fee for further processing varies depending on whether the loss of
rights occurred due to an omitted act (flat rate fee) or the late payment of a fee (50% of that
fee). In some cases, both fees for further processing have to be paid, e.g. if further processing
is requested for the late filing of the request for examination and the late payment of the
examination fee (see paragraph EP.15).
3
For information concerning amended Rule 71 and new Rule 71a EPC, see the Notice from the European Patent Office dated
13 December 2011, OJ EPO 2/2012, 52.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Page 15
(1 March 2018)
PCT Rule 82bis
EPC Art. 122
EPC Rule 136
EP.26 RE-ESTABLISHMENT OF RIGHTS. Re-establishment of rights may be
requested where the applicant lost any right because, in spite of all due care required by the
circumstances having been taken, he was unable to observe a time limit during the international
or the national phase. An application for re-establishment must be filed in writing within two
months from the removal of the cause of non-compliance with the time limit(s) but not later
than one year from the expiration of the time limit(s) which have not been observed. Within
the said two months, the omitted act(s) must be completed, the respective fee(s) for re-
establishment of rights (see Annex EP.I) must be paid and the request must state the grounds on
which it is based and must set out the facts on which it relies. However, reestablishment of
rights is ruled out in respect of any period for which further processing under EPC Article 121
is available. See Guidelines for Examination in the EPO, E-VIII, 3 for more details.
EPC Rule 53(2)
OJ EPO 8-9/2012, 492
Euro-PCT Guide, 613-
623
EP.27 PRIORITY DOCUMENTS. Where the priority of an earlier application is claimed
for a Euro-PCT application, the priority document is sent by the International Bureau to the
EPO, if the International Bureau received the priority document from the receiving Office or
directly from the applicant or was able to retrieve it from a digital library. Where for any
reason the priority document has not been submitted by the time of entry into the national
phase, the applicant will be invited to furnish the missing document(s) within two months from
the date of a notification under EPC Rule 163(2). This time limit cannot be extended. If the
priority document or the application number is not submitted within that time limit, the priority
right is lost. The loss of rights may be remedied by requesting further processing.
OJ EPO 2007 Special
Edition No. 3, A.3
OJ EPO 2014, A98
OJ EPO 2015, A27, A91
A priority document may be filed in electronic form with the EPO only if it is digitally signed
by the issuing authority and the signature is accepted by the EPO. A priority document cannot
be filed by fax.
No obligation to furnish the priority document:
The EPO as designated/elected Office will include a copy of the priority document free of
charge in the file of a Euro-PCT application even without having received a copy from the
International Bureau on condition that the applicant has informed the EPO of the application
number and only if the priority application is:
a European patent application;
an international application filed with the EPO as receiving Office;
a Chinese patent or utility model application;
a Japanese patent or utility model application;
a Korean patent or utility model application;
a United States provisional or non-provisional application.4
EPC Rule 53(3)
OJ EPO 2013, 150
Euro-PCT Guide, 624-
629
Where the language of priority documents is not one of the official languages of the EPO
(English, French or German) and the validity of the priority claim is relevant to the
determination of the patentability of the invention concerned, the applicant is invited to file,
within the time limit specified by the EPO, a translation in one of these three languages or a
declaration that the international application is a complete translation of the priority application.
Failure to comply with this invitation will result in the loss of the right of the relevant priority.
For further information see Guidelines for Examination in the EPO, A-III, 6.8.
PCT Rule 49ter.1
and .2
EPC Art. 122
OJ EPO 2007, 692
Euro-PCT Guide, 630-
636
EP.28 RESTORATION OF PRIORITY. If the international application was filed more
than 12 months from the filing date of the earlier application whose priority is claimed, the
applicant may file a request for restoration of priority with the EPO as designated/elected
Office.
A request for restoration of the right of priority under PCT Rule 49ter.2 may be granted
provided the following requirements are met:
the filing date is within two months from the date on which the priority period
expired (PCT Rule 26bis.2(c)(iii));
4
See the Notice from the European Patent Office dated 27 June 2007 concerning practical aspects of the electronic exchange of
priority documents between the EPO and the USPTO in OJ EPO 8-9/2007, 473 et seq.
EP
Page 16 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
the failure to claim the right of priority within the priority period occurred in spite
of due care required by the circumstances having been taken; thus, the requirement of due care
is applied by the EPO in accordance with its standing practice under EPC Article 122;
a request for restoration of priority is filed within one month from the date on
which the 31-month time limit for entry into the European phase expired
(PCT Rule 49ter.2(b)(i));
the fee for restoration of priority levied by the EPO is duly paid within the same
time limit (PCT Rule 49ter.2(b)(iii));
the request for restoration of priority is accompanied by a statement of reasons for
the failure and is preferably accompanied by any declaration or other evidence in support of the
statement of reasons (PCT Rule 49ter.2(b)(ii)).
EPC Art. 82
EPC Rule 164
OJ EPO 2014, A70
Euro-PCT Guide, 644-
649
EP.29 LACK OF UNITY. If upon expiry of the time limit set in the communication under
EPC Rules 161 and 162 for filing amendments, the documents that serve as the basis for the
supplementary European search or for examination contain claims relating to an invention that
was not searched by the EPO, and the application documents do not meet the requirement of
unity of invention, the procedure under EPC Rule 164 applies (see OJ EPO 2014, A70).
Euro-PCT Guide, 650-
655
The EPO did not act as (S)ISA:
In this case the EPO draws up a partial supplementary European search report on
those parts of the application which relate to the invention first mentioned in the claims and
informs the applicant that, for the supplementary European search report to cover the other
inventions, a further search fee must be paid in respect of each invention involved, within
two months.
The EPO acted as (S)ISA:
Where the supplementary European search report is dispensed with (see
EP.16a) and the examining division considers that in the application documents which are to
serve as the basis for examination an invention is claimed which was not searched by the EPO
as (S)ISA, the examining division shall inform the applicant that a search will be performed in
respect of any such invention for which a search fee is paid within a period of two months.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.II, page 1
(1 March 2018)
1
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
EPA/EPO/OEB 1200.1 – 03.18
Eintritt in die euro-
päische Phase (EPA
als Bestimmungsamt
oder ausgewähltes Amt)
Europäische Anmeldenummer oder, falls
nicht bekannt, PCT-Aktenzeichen oder
PCT-Veröffentlichungsnummer
Zeichen des Anmelders oder Vertreters
(max. 15 Positionen)
Anmelder
Die Angaben über den (die) Anmelder sind
in der internationalen Veröffentli chung
enthalten oder vom Inter natio nalen Büro
nach der internationalen Veröffentlichung
vermerkt worden.
Änderungen, die das Internationale Büro
noch nicht vermerkt hat, sind auf einem
Zusatzblatt angegeben.
Fehlende Angaben über den oder die
Anmelder sind auf einem Zusatzblatt
angegeben.
Zustellanschrift
(siehe Merkblatt II, 1)
Entry into the
European phase
(EPO as designated
RUHOHFWHG2I¿FH
European application number or, if
not known, PCT application or PCT
publication number
Applicant’s or representative’s reference
(max. 15 keystrokes)
Applicant
Indications concerning the applicant(s) are
contained in the international publication or
recorded by the International Bureau after
the international publication.
Changes which have not yet been
recorded by the International Bureau
are set out on an additional sheet.
Indications missing for the applicant(s)
are given on an additional sheet.
Address for correspondence
(see Notes II, 1)
Entrée dans la phase
européenne (l’OEB
agissant en qualité
RI¿FHGpVLJQpRXpOX
Numéro de la demande de brevet
euroen ou, à défaut, numéro de dépôt
PCT ou de publication PCT
Référence du demandeur ou du mandataire
(15 caractères ou espaces au maximum)
Demandeur
Les indications concernant le(s) deman -
GHXUV¿JXUHQWGDQVODSXEOLFDWLRQ
internationale ou ont été enregistrées par
le Bureau international après la publication
internationale.
Les changements qui n’ont pas encore été
enregistrés par le Bureau international sont
indiqués sur une feuille additionnelle.
Les indications manquantes concernant
un ou plusieurs demandeurs sont men-
tionnées sur une feuille additionnelle.
Adresse pour la correspondance
(voir notice II, 1)
An das Euroische Patentamt
7RWKH(XURSHDQ3DWHQW2I¿FH
$O¶2I¿FHHXURSpHQGHVEUHYHWV
Tag des Eingangs / Date of receipt / Date de réception
1XUIUDPWOLFKHQ*HEUDXFK)RURI¿FLDO
use only / Cadre réservé à l’administration
1.
EP
Annex EP.II, page 2 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
2
EPA/EPO/OEB 1200.2 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
5HSUHVHQWDWLYH
Name and DGGUHVVRISODFHRIEXVLQHVV
(Name only one representative or
association of representatives, to be listed
in the Register of European Patents and to
ZKRPFRPPXQLFDWLRQVDUHWREHQRWL¿HG
Additional representative(s)
on additional sheet
Authorisation
Authorisation is attached.
General authorisation is registered
under No.:
$JHQHUDODXWKRULVDWLRQKDVEHHQ¿OHG
but not yet registered.
7KHDXWKRULVDWLRQ¿OHGZLWKWKH(32DV
3&7UHFHLYLQJ2I¿FHH[SUHVVO\LQFOXGHV
the European phase.
Request for examination
Examination of the application under
Article 94 EPC is hereby requested.
The examination fee is being (has been,
will be) paid.
Request for examination in an admissible
non-EPO language
The/Each applicant hereby declares that
he is an entity or a natural person under
Rule 6(4) EPC.
Copies
Additional copies of the documents cited in
the supplementary European search report
are requested.
Number of additional sets of copies
Mandataire
Nom et adresse professionnelle
(N’indiquer qu’un seul mandataire ou le
nom du groupement de mandataires qui
sera inscrit au Registre européen des bre-
YHWVHWDXTXHOOHVVLJQL¿FDWLRQVVHURQWIDLWHV
Fax / Téléfax
Autre(s) mandataire(s)
sur feuille supplémentaire
3RXYRLU
Un pouvoir est joint.
Un pouvoir général est enregistré
sous le n° :
Un pouvoir général a été déposé,
mais n’est pas encore enregistré.
Le pouvoir déposé à l’OEB agissant en
TXDOLWpG¶RI¿FHUpFHSWHXUDXWLWUHGX3&7
inclut expressé ment la phase européenne.
Requête en examen
Il est demandé par la présente que soit
examinée la demande de brevet conformé-
ment à l’article 94 CBE. Il est (a été, sera)
procédé au paiement de la taxe d’examen.
Requête en examen dans une langue
QRQRI¿FLHOOHDXWRULVpH
Le/Chaque demandeur déclare par la
présente être une entité ou une personne
physique au sens de la règle 6(4) CBE.
Copies
Prière de fournir des copies
supplémentaires des documents cités dans
le rapport complémentaire de recherche
européenne.
Nombre de jeux supplémentaires
de copies
Vertreter
Name und Geschäftsanschrift
(Nur einen Vertreter oder den Namen des
Zusammenschlusses angeben, der in das
Euro päische Patentregister einzutragen ist
und an den zugestellt wird)
Telefon / Telephone / Téléphone
Weitere(r) Vertreter
auf Zusatzblatt
Vollmacht
Vollmacht ist beigefügt.
Allgemeine Vollmacht ist registriert
unter Nr:
Allgemeine Vollmacht ist eingereicht,
aber noch nicht registriert.
Die beim EPA als PCT-Anmeldeamt
eingereichte Vollmacht schließt aus-
drücklich die europäische Phase ein.
Prüfungsantrag
Hiermit wird die Prüfung der Anmel dung
gemäß Artikel 94 EPÜ beantragt. Die
Prüfungsgebühr wird (wurde) entrich tet.
Prüfungsantrag in einer zugelassenen
Nichtamtssprache
Der/Jeder Anmelder erkrt hiermit, eine
Einheit oder eine natürliche Person nach
Regel 6 (4) EPÜ zu sein.
$EVFKULIWHQ
Zusätzliche Abschriften der im
ergänzenden europäischen Recherchen-
bericht angeführten Schriftstücke werden
beantragt.
Anzahl der zusätzlichen Sätze von
Abschriften
2.
3.
4.
4.1
5.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.II, page 3
(1 March 2018)
3
EPA/EPO/OEB 1200.3 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
Documents intended for
SURFHHGLQJVEHIRUHWKH(32
Proceedings before the EPO as
GHVLJQDWHG2I¿FH (PCT I) are to be
based on the following documents:
the DSSOLFDWLRQGRFXPHQWVSXEOLVKHG
by the International Bureau; where the
publication includes a set of claims
amended under Article 19 PCT, the latter
UHSODFHVWKHRULJLQDOO\¿OHGFODLPV
unless replaced by the amend ments
enclosed.
Comments on the written opinion esta-
blished by the EPO as the International
Searching Authority and/or observations
or, where applicable, on the explanations
given in the Supplementary Internatio-
nal Search Report established by the
EPO as the Supplementary International
Searching Authority (Rule 45bis.7(e) PCT)
Where necessary, further details should
be submitted on an additional sheet.
Proceedings before the EPO as elected
2I¿FH (PCT II) are to be based on the
following documents:
the documents on which the inter-
national preliminary examination
UHSRUWLVEDVHG, including any annexes
unless replaced by the amend ments
enclosed.
Comments on the international
preliminary examination report
established by the EPO as the
International Preliminary Examining
Authority and/or observations are
enclosed.
Where necessary, further details should
be submitted on an additional sheet.
If the EPO as International Prelimi nary
Examining Author ity has received test
reports, these may be used as the basis
of pro ceedings before the EPO.
Note on sections 6.1 and 6.2:
For applications comprising more than
35 pages, indications regarding the
calculation of the additional fee should be
given in the table on page 8.
For each of the previous applications
whose priority is claimed a copy is
attached of the search results produced
by the authority with which the application
ZDV¿OHG5XOH(3&
Pièces destinées à la procédure
GHYDQWO¶2(%
La procédure devant l’OEB agissant en
qualité d’RI¿FHGpVLJQp (PCT I) doit se
fonder sur les pièces suivantes :
les SLqFHVGHODGHPDQGHSXEOLpHV par
le Bureau international; lorsque la publica-
WLRQFRQWLHQWGHVUHYHQGLFDWLRQVPRGL¿pHV
conformément à l’article 19 PCT, ces der-
nières remplacent les revendications telles
que déposées initialement
dans la mesure où elles ne sont pas rem-
placées par les PRGL¿FDWLRQV join tes.
Commentaires sur l’opinion écrite établie
par l’OEB agissant en qualité d’administra-
tion chargée de la recherche internationale
et/ou observations, ou, le cas échéant,
FRPPHQWDLUHVVXUOHVH[SOLFDWLRQV¿JXUDQW
dans le rapport de recherche internatio-
nale supplémentaire établi par l’OEB
agissant en qualité d’administration
chargée de la recherche internationale
supplé mentaire (règle 45bis.7e) PCT)
Le cas échéant, des informations com-
plémentaires doivent être fournies sur
une feuille additionnelle.
La procédure devant l’OEB agissant en
qualité d’RI¿FHpOX (PCT II) doit se fonder
sur les pièces suivantes :
les pièces sur lesquelles se fonde le
rapport d’examen préliminaire inter-
national, y compris ses annexes éven-
tuelles
dans la mesure où elles ne sont pas rem-
placées par les PRGL¿FDWLRQV jointes.
Les commentaires sur le rapport
d’examen préliminaire international
établi par l’OEB agissant en qualité
d’administration chargée de l’examen
préliminaire international et/ou les
observations sont joints.
Le cas échéant, des informations com-
plémentaires doivent être fournies sur
une feuille additionnelle.
Si l’OEB, agissant en qualité d’administra -
tion chargée de l’examen prélimi naire inter-
national, a reçu des rapports d’essais,
ceux-ci peuvent être utilisés comme base
dans la procédure devant l’OEB.
Remarque concernant les rubriques
6.1 et 6.2 : pour les demandes comportant
plus de 35 pages, des indications relatives
au calcul de la taxe additionnelle doivent
¿JXUHUGDQVODWDEOHDXGHODSDJH
Il est joint une copie des résultats de toute
recherche effectuée par l’adminis tration au-
près de laquelle la (les) demande(s) anté-
rieure(s) dont la priorité est revendi quée a
(ont) été déposée(s) (règle 141(1) CBE).
)UGDV9HUIDKUHQYRUGHP(3$
EHVWLPPWH8QWHUODJHQ
Dem Verfahren vor dem EPA als
Bestimmungs amt (PCT I) sind fol gende
Unterlage n zugrunde zu legen:
die vom Internationalen Büro YHU|IIHQW
lichten Anmeldungsunter lagen; falls
die Veröffentlichung einen geänderten
Anspruchssatz gemäss Artikel 19 PCT
enthält, ersetzt dieser die ursprünglich
eingereichten Ansprüche
soweit sie nicht ersetzt werden durch
die beigefügten Änderungen.
Stellungnahmen zu dem vom EPA als
Internationaler Recherchen be hörde
erstellten schriftlichen Bescheid und/
oder Bemerkungen bzw. Stellungnah-
men zu den Erläuterungen in dem
vom EPA als mit der ergänzenden
internationalen Recherche beauftrag-
ten Behörde erstellten ergänzenden
internatio nalen Recherchenbericht
(Regel 45bis.7 e) PCT)
Soweit erforderlich, sind weitere Angaben
auf einem Zusatzblatt einzureichen.
Dem Verfahren vor dem EPA als aus-
ge wähltem Amt (PCT II) sind fol gende
Unter lagen zugrunde zu legen:
die dem LQWHUQDWLRQDOHQYRUOlX¿JHQ
3UIXQJVEHULFKW]XJUXQGHJHOHJWHQ
8QWHUODJHQ, ein schließlich etwaiger
An lagen
soweit sie nicht ersetzt werden durch
die beige fügten Än de rungen.
Stellungnahmen zu dem vom EPA
DOVPLWGHULQWHUQDWLRQDOHQYRUOlX¿JHQ
Prüfung beauftragter Behörde
HUVWHOOWHQLQWHUQDWLRQDOHQYRUOlX¿JHQ
Prüfungsbericht und/oder
Bemerkungen sind beigefügt.
Soweit erforderlich, sind weitere Angaben
auf einem Zusatzblatt einzureichen.
Sind dem EPA als mit der internatio-
QDOHQYRUOlX¿JHQ3UIXQJEHDXIWUDJWHU
Behörde 9HUVXFKVEHULFKWH zugegan gen,
dürfen diese dem Ver fahren vor dem EPA
zugrunde ge legt wer den.
Anmerkung zu den Feldern 6.1 und 6.2:
Bei Anmeldungen, die mehr als 35 Seiten
umfassen, sollen in der Tabelle auf Seite 8
Angaben betreffend die Berechnung der
Zusatzgebühren gemacht werden.
Eine Kopie der Recherchenergebnisse
der Behörde, bei der die frühere(n)
Anmeldung(en), deren Priorität bean-
sprucht wird, eingereicht wurde(n),
ist beigefügt (Regel 141 (1) EPÜ).
6.
6.1
6.2
6.3
EP
Annex EP.II, page 4 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
4
EPA/EPO/OEB 1200.4 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
hEHUVHW]XQJHQ
Beigefügt sind die nachfolgend angekreuz-
ten Übersetzungen in einer der Amtsspra-
chen des EPA (Deutsch, Englisch, Franzö-
sisch):
a) Im Verfahren vor dem EPA als
Bestim mungsamt oder ausgewähltem
Amt (PCT I + II):
Übersetzung der internationalen Anmel-
dung in der ursprünglich eingereichten
Fassung (Beschreibung, An sprüche, etwai-
ge Text bestand teile in den Zeichnungen),
der veröffent lichten Zusammenfas sung und
etwai ger Angaben über bio lo gisches Mate-
rial nach Re ge l 13bis.3 und 13bis.4 PCT
Übersetzung der SULRULWlWVEHJUQGHQGHQ
Anmeldung(en) (nur nach Aufforderung
durch das EPA, Regel 53 (3) EPÜ)
Es wird hiermit erklärt, dass die interna-
tionale Anmeldung in ihrer ursprünglich
eingereichten Fassung eine vollständige
Übersetzung der früheren An meldung ist
(Regel 53 (3) EPÜ).
b) Zusätzlich im Verfahren vor
dem EPA als Bestimmungsamt (PCT I):
Übersetzung der nach Artikel 19 PCT
geänderten Ansprüche nebst Erklärung,
falls diese dem Verfahren vor dem EPA
zugrunde gelegt werden sollen (siehe
Feld 6).
c) Zusätzlich im Verfahren vor dem
EPA als ausgewähltem Amt (PCT II):
Übersetzung der Anlagen zum internatio-
QDOHQYRUOlX¿JHQ3UIXQJVEHULFKW
Biologisches Material
'LH(U¿QGXQJYHUZHQGHWXQGRGHUEH]LHKW
sich auf biologisches Material, das nach
Regel 31 EPÜ hinterlegt worden ist.
Die $QJDEHQQDFK5HJHOF(3h
(falls noch nicht bekannt, die Hinterle-
gungs stelle und das (die) vom Hinterleger
zugeteilte(n) Bezugszeichen [Nummer,
Symbole usw.]) sind in der internationalen
Veröffentli chung oder in der gemäß Feld 7
einge reichten Über setzung enthalten auf
Seite(n)/Zeile(n):
Die (PSIDQJVEHVFKHLQLJXQJHQ der
Hinterlegungsstelle
ist (sind) beigefügt.
wird (werden) nachgereicht.
9HU]LFKWDXIGLH9HUSÀLFKWXQJGHV$QWUDJ
stellers nach Regel 33 (2) EPÜ auf
gesondertem Schriftstück
Translations
7UDQVODWLRQVLQRQHRIWKHRI¿FLDO
langua ges of the EPO (English, French,
German) are enclosed as crossed below:
(a) In proceedings before the EPO as
GHVLJQDWHGRUHOHFWHG2I¿FH (PCT I + II):
Translation of the inter natio nal
ap plication (des cription, claims, any
text in the dra wings) DVRULJLQDOO\¿OHG,
of the ab stract as publis hed and of any
indica tion under Rule 13bis.3 and 13bis.4
PCT regarding biological material
Translation of the priority appli cation(s)
WREH¿OHGRQO\DWWKH(32¶VUHTXHVW
Rule 53(3) EPC)
It is hereby declared that the international
DSSOLFDWLRQDVRULJLQDOO\¿OHGLVDFRPSOHWH
translation of the previous application
(Rule 53(3) EPC).
(b) In addition, in proceedings before
the EPO as GHVLJQDWHG2I¿FH (PCT I):
Translation of amended claims and
any state ment un der Article 19 PCT, if
the claims as amended are to form the
basis for the procee dings before the EPO
(see Section 6).
(c) In addition, in proceedings before
the EPO as HOHFWHG2I¿FH (PCT II):
Translation of any annexes to the inter-
natio nal preliminary exami nation report
Biological material
The invention uses and/or relates to
biological material deposited under
Rule 31 EPC.
The particulars referred to in Rule 31(1)
(c) EPC (if not yet known, the depository
LQVWLWXWLRQDQGWKHLGHQWL¿FDWLRQ
reference(s) [number, symbols, etc.] of the
depositor) are given in the international
publication or in the trans lation submitted
under Section 7 on page(s)/line(s):
The receipt(s) of deposit issued by the
depositary institution
is (are) enclosed.
ZLOOEH¿OHGODWHU
Waiver of the right to an undertaking from
the requester pursuant to Rule 33(2) EPC
attached
Traductions
Vous trouverez, ci-joint, les traductions
cochées ci-après dans l’une des langues
RI¿FLHOOHVGHO¶2(%DOOHPDQGDQJODLV
français) :
a) Dans la procé dure devant l’OEB
agissant en qualité d’RI¿FHGpVLJQp
RXpOX(PCT I + II) :
Traduction de la demande inter na -
tionale telle que déposée initiale ment
GHVFULSWLRQUHYHQGLFDWLRQVWH[WHV¿JXUDQW
éventuelle ment dans les des sins), de
l’abrégé publié et de toutes indications
visées aux règles 13bis.3 et 13bis.4 PCT
concernant le matériel biologique
Traduction de la (des) demande(s) dont
ODSULRULWpHVWUHYHQGLTXpH(à produire
seulement sur invitation de l’OEB,
règle 53(3) CBE)
Il est déclaré par la présente que la de-
mande internationale telle que déposée
initialement est une traduction intégrale de
la demande antérieure (règle 53(3) CBE).
b) De plus, dans la procédure devant l’OEB
agissant en qualité d’RI¿FHGpVLJQp (PCT I) :
Traduction des UHYHQGLFDWLRQVPRGL¿pHV
et de la déclaration faite confor mément
à l’article 19 PCT, si la pro dure devant
l’OEB doit être fondée sur les reven dications
PRGL¿pHVYRLUODUXEULTXH
c) De plus, dans la procédure devant l’OEB
agissant en qualité d’RI¿FHpOX (PCT II) :
Traduction des annexes du rapport
d’examen préliminaire inter national
0DWLqUHELRORJLTXH
L’invention utilise et/ou concerne de la
matière biologique déposée conformé ment
à la règle 31 CBE.
Les LQGLFDWLRQVYLVpHVjODUqJOHF
CBE (si elles ne sont pas encore connues,
l’autorité de dépôt et la (les) référence(s)
G¶LGHQWL¿FDWLRQ>QXPpURRXV\PEROHVHWF@
GXGpSRVDQW¿JXUHQWGDQVODSXEOLFDWLRQ
internationale ou dans la traduction pro-
du ite con formé ment à la rubrique 7 à la/aux
page(s)/ligne(s) :
Le(s) récépissé(s) de dépôt délivré(s)
par l’autorité de dépôt
est (sont) joint(s).
sera (seront) produit(s) ultérieurement.
Renonciation, sur document distinct,
à l’engagement du requérant au titre de
la règle 33(2) CBE
7.
7.1
7.2
7.3
7.4
7.5
8.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.II, page 5
(1 March 2018)
5
EPA/EPO/OEB 1200.5 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
Séquences de nucléotides et
d’acides aminés
Les pièces requises conformément aux
règles 5.2 et 13ter PCT et aux règles 30 et
163(3) CBE ont déjà été déposées auprès
de l’OEB.
Le listage des séquences sous forme
électronique est fourni ci-joint conformé-
ment aux règles 30 et 163(3) CBE.
Le listage des séquences ne s’étend pas
au-delà du contenu de la demande telle
qu’elle a été déposée.
Désignation d'Etats contractants
Tous les Etats contractants qui sont
parties à la CBE lors du dépôt de la
GHPDQGHGHEUHYHWLQWHUQDWLRQDOH et
sont désignés dans la demande inter-
nationale sont réputés désignés (voir
article 79(1) CBE).
Extension/Validation
La présente demande est réputée
constituer une requête en extension des
effets de la demande de brevet européen
et du brevet euroen délivré sur la base
de cette demande à tous les Etats non
parties à la CBE qui sont désignés dans la
demande internationale et avec lesquels
des accords d’extension ou de validation
étaient en vigueur à la date du dépôt de
la demande. Cette requête est toutefois
réputée retirée si la taxe d’extension ou,
le cas écant, la taxe de validation n’est
pas acquittée en temps utile.
Il est envisagé de payer la(les) taxe(s)
d’extension pour les Etats suivants :
Veuillez noter que dans le cadre de la
produre de prélèvement automatique
des taxes d’extension, le compte est
débité du montant dû seulement pour les
Etats cochés ici, sauf instruction contraire
reçue avant l’expiration du délai de
paiement.
Bosnie-Herzégovine
Monténégro
(Espace prévu pour des Etats désignés dans
la demande internationale avec lesquels des
accords d’extension existaient à la date de
dépôt de la demande internationale)
Nucleotide and amino acid
sequences
The items pursuant to Rules 5.2 and
13ter PCT, Rules 30 and 163(3) EPC
are already with the EPO.
The sequence listing is furnished herewith
in electronic form in accordance with
Rules 30 and 163(3) EPC.
The sequence listing does not include
matter which goes beyond the application
DV¿OHG
Designation of contracting states
All the contracting states party to the EPC
DWWKHWLPHRI¿OLQJRIWKHLQWHUQDWLRQDO
patent application and designated in the
international application are deemed to be
designated (see Article 79(1) EPC).
Extension/Validation
This application is deemed to be a
request to extend the effects of the
European patent application and the
European patent granted in respect of it
to all non-contracting states to the EPC
designated in the international application
with which extension or validation
agreements were in force on the date on
ZKLFKWKHDSSOLFDWLRQZDV¿OHG+RZHYHU
the request is deemed withdrawn if the
extension fee or validation fee, whichever
is applicable, is not paid within the
prescribed time limit.
It is intended to pay the extension fee(s)
for the following state(s):
Note: Under the automatic debiting
procedure, extension fees will be debited
only for states indicated here, unless the
EPO is instructed otherwise before expiry
of the period for payment.
Bosnia and Herzegovina
Montenegro
(Space for states which were designated in
the international application and with which
extension agreements existed on the date
RI¿OLQJRIWKHLQWHUQDWLRQDODSSOLFDWLRQ
Nucleotid- und Aminosäure-
sequenzen
Die nach den Regeln 5.2 und 13ter PCT
sowie den Regeln 30 und 163 (3) EPÜ
erforderli chen Unterlagen liegen dem
EPA bereits vor.
Das Sequenzprotokoll wird anliegend in
elektronischer Form gemäß den Regeln
30 und 163 (3) EPÜ nachgereicht.
Das Sequenzprotokoll geht nicht
über den Inhalt der Anmeldung in
der ursprünglich eingereichten Form
hinaus.
%HQHQQXQJYRQ9HUWUDJVVWDDWHQ
Alle Vertragsstaaten, die dem EPÜ EHL
Einreichung der internationalen Patent-
anmeldung angehören, gelten als benannt
(siehe Artikel 79 (1) EPÜ), soweit sie in der
internationalen Anmeldung bestimmt sind.
Erstreckung/Validierung
Diese Anmeldung gilt als Antrag, die
europäische Patentanmeldung und das
darauf erteilte europäische Patent auf
alle in der internationalen Anmeldung
bestimmten Nichtvertragsstaaten des
EPÜ zu erstrecken, mit denen am Tag
der Einreichung der internationalen
Anmeldung Erstreckungs- oder Validie-
rungsabkommen in Kraft waren. Der
Antrag gilt jedoch als zuckgenommen,
wenn die Erstreckungs- bzw. die Validie-
rungsgebühr nicht fristgerecht entrichtet
wird.
Es ist beabsichtigt, die Erstreckungsge-
bühr(en) für folgende Staaten zu entrichten:
Hinweis: Im automatischen Abbuchungs-
verfahren werden nur für die hier ange-
kreuzten Staaten Erstreckungsgebühren
abgebucht, sofern dem EPA nicht vor
Ablauf der Zahlungsfrist ein anders-
lautender Auftrag zugeht.
BA Bosnien und Herzegowina
ME Montenegro
(Platz für in der internationalen Anmeldung
bestimmte Staaten, mit denen Erstreckungs-
abkommen am Anmeldetag der internatio-
nalen Anmeldung in Kraft waren)
9.
9.1
9.2
10.
11.
11.1
EP
Annex EP.II, page 6 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
6
EPA/EPO/OEB 1200.6 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
11.2
12.
12.1
12.2
13.
14.
Es ist beabsichtigt, die Validierungsge-
bühr(en) für folgende Staaten zu entrichten:
Hinweis: Im automatischen Abbuchungs-
verfahren werden nur für die hier ange-
kreuzten Staaten Validierungsgebühren
abgebucht, sofern dem EPA nicht
vor Ablauf der Zahlungsfrist ein
anderslautender Auftrag zugeht.
KH Kambodscha
MA Marokko
MD Republik Moldau
TN Tunesien
(Platz für in der internationalen Anmeldung
bestimmte Staaten, mit denen Validierungs-
abkommen nach Drucklegung dieses
Formblatts in Kraft treten)
Beschleunigung des Verfahrens
9RU]HLWLJH%HDUEHLWXQJ
Hiermit wird die vorzeitige Bearbeitung
der Anmeldung gemäß Artikel 23 (2) /
40 (2) PCT beantragt („vorzeitiger
Bearbeitung in die europäische Phase“).
Î Bitte beachten Sie die Erfordernisse,
die für einen wirksamen Antrag auf vor -
zeitige Bearbeitung erfüllt werden müssen,
sowie dessen rechtliche Konsequenzen
(s. „Merkblatt zum Formblatt EPA 1200“).
Verzichtserklärungen
Der Anmelder verzichtet auf die Mitteilung
nach Regel 161 (1) oder (2) und 162 EPÜ.
Der Anmelder verzichtet auf die Aufforde-
rung nach Regel 70 (2) EPÜ, zu erklären,
ob die Anmeldung aufrechterhalten wird.
Zahlungen
Bezüglich der Gebührenentrichtung,
insbesondere über das laufende Konto,
wird auf Abschnitt 13 des Merkblatts
zum Formblatt für den Eintritt in
die europäische Phase (EPA als
Bestimmungsamt oder ausgewähltes
Amt) (Formblatt EPA/EPO/ OEB 1200)
verwiesen.
Etwaige Rückzahlungen sollen
DXIGDVXQWHQVWHKHQGHEHLP(3$
geführte laufende Konto erfolgen
Nummer und Kontoinhaber
It is intended to pay the validation fee(s)
for the following state(s):
Note: Under the automatic debiting
procedure, validation fees will be debited
only for states indicated here, unless the
EPO is instructed otherwise before expiry
of the period for payment.
Cambodia
Morocco
Republic of Moldova
Tunisia
(Space for states which were designated in
the international application and with which
validation agreements enter into force after
this form has been printed)
Acceleration of procedure
Early processing
Early processing of the application
pursuant to Article 23(2) / 40(2) PCT is
hereby requested (“early entry into the
European phase”).
Î Please take note of the further
requirements for the request to be
effective and the legal consequences
(see “Notes on EPO Form 1200”).
:DLYHUV
The applicant waives his right to the
communication under Rules 161(1) or (2)
and 162 EPC.
The applicant waives his right to be asked
under Rule 70(2) EPC whether he wishes
to proceed further with the application.
Payment
With regard to the payment of fees, in
particular via deposit account, reference is
made to Section 13 of the Notes on Form
EPA/EPO/OEB 1200 for entry into the
European phase (EPO as designated or
HOHFWHG2I¿FH
$Q\UHIXQGVVKRXOGEHPDGHWR
WKH(32GHSRVLWDFFRXQWEHORZ
Number and account holder
Il est envisagé de payer la(les) taxe(s) de
validation pour les Etats suivants :
Veuillez noter que dans le cadre de la
procédure de prélèvement automatique
des taxes de validation, le compte est dé-
bité du montant dû seulement pour les Etats
cochés ici, sauf instruction contraire reçue
avant l’expiration du délai de paiement.
Cambodge
Maroc
République de Moldavie
Tunisie
(Espace prévu pour des Etats désignés dans
la demande internationale avec lesquels des
accords de validation entreront en vigueur
après l’impression du présent formulaire)
Accélération de la procédure
Traitement anticipé
Par la présente, le traitement anticipé de
la demande selon les articles 23(2) / 40(2)
PCT est demandé (« entrée anticipée
dans la phase européenne»).
Î Prière de noter les conditions requises
à remplir pour qu’une requête en traite-
ment anticipé soit valable, ainsi que les
conséquences juridiques (voir la « Notice
concernant le formulaire OEB 1200 »).
Renonciations
Le demandeur renonce au droit de
UHFHYRLUODQRWL¿FDWLRQpPLVHHQYHUWXGHV
règles 161(1) ou (2) et 162 CBE.
Le demandeur renonce à être invité,
conformément à la règle 70(2) CBE, à dé-
clarer s’il souhaite maintenir sa demande.
Paiement
En ce qui concerne le paiement des taxes,
en particulier via un compte courant, ii
est fait reference a la rubrique 13 de la
notice concernant le formulaire EPA/EPO/
OEB 1200 relatif a l‘entree dans la phase
europeenne (OEB agissant en quallte
GµRI¿FHGHVLJQHRXHOX
/HVUHPERXUVHPHQWVpYHQWXHOV
GRLYHQWrWUHHIIHFWXpVVXUOH
compte courant ci-dessous
RXYHUWDXSUqVGHO¶2(%
Numéro et titulaire du compte
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.II, page 7
(1 March 2018)
7
EPA/EPO/OEB 1200.7 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
15. 8QWHUVFKULIWHQGHVGHU
Anmelder(s) oder Vertreter
Name(n) des (der) Unterzeichneten bitte
in Druck schrift wiederholen und bei
juristischen Personen auch die Stellung
des (der) Unter zeichneten innerhalb der
Gesellschaft angeben.
Für Angestellte (Art. 133 (3) EPÜ)
mit allgemeiner Vollmacht Nr.:
Ort / Datum
Signature(s) of applicant(s) or
UHSUHVHQWDWLYH
Under signature please print name and,
in the case of legal persons, position
within the company.
For employees (Art. 133(3) EPC)
with general authorisation No.:
Place / Date
Signature(s) du (des) demandeur(s)
ou du mandataire
Prière d’indiquer en caractères d’im-
primerie le ou les noms des signataires
ainsi que, s’il s’agit d’une personne
morale, la position occupée au sein de
celle-ci par le ou les signataires.
Pour les employés (art. 133(3) CBE)
GLVSRVDQWG¶XQSRXYRLUJpQpUDOQ
Lieu / Date
EP
Annex EP.II, page 8 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
8
EPA/EPO/OEB 1200.8 – 03.18
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur 8
Zeichen des Anmelders / Applicant’s
reference / Référence du demandeur
7DEHOOH]X)HOG
GHV)RUPEODWWV
7DEOHIRUVHFWLRQ
of Form 1200.3
7DEOHDXDIIpUHQW
jODUXEULTXH
du formulaire 1200.3
'HU%HUHFKQXQJGHU=XVDW]JHEKU]XJUXQGH]XOHJHQGH8QWHUODJHQ$UW1UD*HE2 1 /
'RFXPHQWVRQZKLFKWKHFDOFXODWLRQRIWKHDGGLWLRQDOIHHLVEDVHG
$UWLWHPD5)HHV1 / Pièces fondant le calcul de la taxe
DGGLWLRQQHOOHDUWSRLQWELV5571
Seite(n) von ... bis ...2 Anzahl der Seiten3
Page(s) from ... to ...2 Number of pages3
Page(s) ... à ...2 Nombre de pages3
Anzahl der Seiten insgesamt / Total number of pages /
Nombre total de pages
Gebührenfreie Seiten (Art. 2 Nr. 1a GebO) / Fee-exempt pages (Art. 2, item 1a, RFees)
/ Pages exemptes de taxes (art. 2, point 1bis RRT)
$Q]DKOGHUJHEKUHQSÀLFKWLJHQ6HLWHQ1XPEHURISDJHVWREHSDLGIRU
Nombre de pages soumises au paiement de la taxe
Veröffentlichte Fassung der
inter nationalen Anmeldung /
International application as
published /
Demande internationale telle que
publiée
Geänderte Ansprüche nach Art. 19 PCT (veröffentlicht mit der internationalen
Anmeldung oder gesondert veröffentlicht) /
Amended claims under Art. 19 PCT (published with the international application or
published separately) /
5HYHQGLFDWLRQVPRGL¿pHVHQYHUWXGHO¶DUW3&7WHOOHVTXHSXEOLpHVDYHFOD
demande internationale ou telles que publiées séparément)
Beschreibung / description / description
Ansprüche / claims / revendications
Zeichnungen / drawings / dessins
Zusammenfassung / abstract / abrégé
Beschreibung / description / description
Ansprüche / claims / revendications
Zeichnungen / drawings / dessins
Beschreibung / description / description
Ansprüche / claims / revendications
Zeichnungen / drawings / dessins
Beim Eintritt in die europäische
Phase eingereichte Änderungen /
$PHQGPHQWV¿OHGRQHQWU\LQWR
European phase /
0RGL¿FDWLRQVSUpVHQWpHVORUVGH
l'ente dans la phase européenne
Änderungen nach Art. 34 PCT /
Amendments under Art. 34 PCT /
0RGL¿FDWLRQVHQYHUWXGH
l'art. 34 PCT
35
(85
(x 15 EUR pro Seite) / (x EUR 15 per page) / (x 15 euros par page)
Zu entrichtender Gesamtbetrag
Total amount payable
Montant total exigible en euros
1
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.II, page 9
(1 March 2018)
9
EPA/EPO/OEB 1200.9 – 03.18
9
Fußnoten
Zu Fällen, in denen die internationale
Anmeldung nicht in einer Amtssprache
des EPA veröffentlicht wurde, siehe die
Mitteilung zur Ergänzung der Mitteilung
des Europäischen Patentamts vom
26. Januar 2009 über die Gebühren-
struktur 2009 (ABl. EPA 2009, 338).
In dieser Spalte sind nur die Seiten
an zu geben, die der Berechnung der
Zusatzgebühr (Art. 2, Nr. 1a GebO)
zugrunde zu legen sind. Verbleibende
Seiten/Teile der veröffentlichten Fassung
der Anmeldung und/oder der gemäß
Artikel 19 PCT und/oder Artikel 34
PCT geänderten Anmeldung, die zu
ersetzen sind, sind nicht in dieser Spalte
anzugeben.
In dieser Spalte ist nur die Zahl der
Seiten anzugeben, die der Berechnung
der Zusatzgebühr (Art. 2, Nr. 1a GebO)
zugrunde zu legen sind.
Footnotes
For cases where the international
application has not been published in
DQRI¿FLDOODQJXDJHRIWKH(32VHHWKH
Notice supplementing the Notice from the
(XURSHDQ3DWHQW2I¿FHGDWHG-DQXDU\
2009 concerning the 2009 fee structure
(OJ EPO 2009, 338).
Only those pages to be taken into
account for the calculation of the
additional fee (Art. 2, item 1a, RFees)
shall be indicated in this column.
Any remaining pages/parts of the
application as published and/or amended
under Article 19 PCT and/or Article 34
PCT which are to be replaced shall not
be indicated in this column.
Only the number of pages to be taken
into account for the calculation of the
additional fee (Art. 2, item 1a, RFees)
shall be indicated in this column.
1RWHVGHEDVGHSDJH
Pour les cas où à la demande inter-
nationale n’a pas été publiée dans une
ODQJXHRI¿FLHOOHGHO2(%FI&RPPXQLTXp
FRPSOpWDQWOHFRPPXQLTXpGHO¶2I¿FH
euroen des brevets, en date du
26 janvier 2009, relatif à la structure
des taxes 2009 (JO OEB 2009, 338).
Il convient de n'indiquer dans cette
colonne que les pages devant être prises
en considération pour le calcul de la taxe
additionnelle (art. 2, point 1bis RRT).
Si la demande telle que publiée et/ou
PRGL¿pHDXWLWUHGHODUWLFOH3&7
et/ou de l'article 34 PCT contient
d'autres pages/parties qui doivent être
remplacées, prre de ne pas mentionner
les pages/parties en question dans cette
colonne.
Il convient de n'indiquer dans cette
colonne que le nombre de pages devant
être prises en considération pour le
calcul de la taxe additionnelle (art. 2,
point 1bis RRT).
1
2
3
EP
Annex EP.II, page 10 PCT Applicant’s Guide National Phase National Chapter – EP
(1 March 2018)
1
EPO 1200 Notes 03.18
Notes on EPA/EPO/OEB Form 1200 for entry into the European phase
(EPO as designated or elected Office)
I. General instructions
These notes explain how to complete
EPA/EPO/OEB Form 1200. To file international
applications under the Patent Cooperation Treaty
(PCT) Form PCT/RO/101 should be used. The
appropriate form to request the grant of a
European patent is EPA/EPO/OEB Form 1001.
The requirements for entry into the European
phase are laid down in the European Patent
Convention (EPC) and its Implementing
Regulations. Further information on entry into the
European phase can be obtained from the Euro-
PCT Guide: PCT procedure at the EPO (10th
edition, January 2017), in particular Section E:
Euro-PCT procedure before the EPO as a
designated (PCT Chapter I) or elected (PCT
Chapter II) Office.
Forms and brochures
Forms, brochures, schedules of fees and legal
texts can be downloaded from the EPO's website
at www.epo.org.
Accelerated prosecution
For those seeking faster search or examination
for their applications, the "PACE" programme for
accelerated prosecution of European patent
applications (OJ EPO 2015, A93) offers effective
options for shortening the processing time.
However, PACE requests filed before the end of
the international phase will not be effective unless
accompanied by an express request for early
processing under Article 23(2) or 40(2) PCT (see
point 12.1).
For other ways to expedite the European grant
procedure, see Notice from the EPO dated
30 November 2015 (OJ EPO 2015, A94) and
point 12.
Entry into the European phase Form 1200
Under Rule 159(1) EPC, on entry into the
European phase before the EPO as designated or
elected Office applicants must perform the acts
specified in Rules 159(1)(a) to (h) and 162(1)
EPC within 31 months of the filing date or, if
priority has been claimed, the (earliest) priority
date.
Use of Form 1200 is recommended. The form
should be typewritten or printed (Rule 50(2) EPC)
to ensure that it is machine-readable.
If there is not enough space for the required
information, an additional sheet should be filed,
indicating the number and heading (e.g. "2 -
Additional representative(s)"; "6 - Documents
intended for proceedings before the EPO") of
each section continued in this way.
Filing of documents
Form 1200 and attachments must be filed direct
with the EPO.
(a) Online
Form 1200, attached translations and
amendments to the application documents may
be filed in electronic form (OJ EPO 2015, A91),
i.e. via EPO online filing, via the EPO case
management system (CMS, also referred to as
new online filing) or via the EPO web-form filing
service. For more details go to www.epo.org. The
online filing fee is less than the fee for filing in
person, by post or by fax.
(b) By fax
The above documents may also be filed by fax.
Confirmation on paper is required only if the EPO
specifically requests it (see Special edition No. 3,
OJ EPO 2007, A.3.).
(c) By post or in person
Form 1200 need only be filed in one copy. The
same applies to attached translations and
amendments to the application documents.
Special rules apply to sequence listings (see II.9).
II. Filling in the form
The numbering below corresponds to the sections
of the form.
1. Applicant
If on entry into the European phase the address,
nationality, or country of residence or of place of
business is missing for any applicant (as may
occur under Rule 26.2bis(b) PCT), this
information must be filed on a separate sheet.
EP
PCT Applicant’s Guide National Phase National Chapter – EP Annex EP.II, page 11
(1 March 2018)
2
EPO 1200 Notes 03.18
An address for correspondence may be given
only by applicants who are not obliged to appoint
a professional representative authorised to act
before the EPO (Article 133 EPC) and have not
appointed one. It must be the applicant’s own
address, and in an EPC contracting state.
Addresses for correspondence accepted for
proceedings in the international phase but which
do not fulfil those conditions will not be accepted
in proceedings before the EPO in the European
phase (see OJ EPO 2014, A99).
2. Representative (Articles 133 and 134 EPC)
Applicants not having their residence or principal
place of business in an EPC contracting state
must be represented by a professional
representative and act through him in all
proceedings established by the EPC
(Article 133(2) EPC).
3. Authorisation (Rule 152 EPC)
Under Rule 152(1) to (3) EPC in conjunction with
the decision of the President of the EPO dated
12 July 2007, professional representatives who
identify themselves as such are required to file a
signed authorisation only in particular
circumstances (see Special edition No. 3,
OJ EPO 2007, L.1). However, a legal practitioner
entitled to act as professional representative
under Article 134(8) EPC or an employee acting
for an applicant under Article 133(3), first
sentence, EPC who is not a professional
representative must file a signed authorisation
unless an authorisation which expressly
empowers him to act in proceedings established
by the EPC has previously been filed with the
EPO as receiving Office.
If an association registered with the EPO is
appointed as representative (Rule 152(11) EPC)
(see OJ EPO 2013, 535), the association’s
registered name and registration number must be
indicated.
If an authorisation is required, the use of
EPA/EPO/OEB Form 1003 is recommended for
individual authorisations and EPO Form 1004 for
general authorisations.
4. Request for examination (Articles 150(2) and
94 and Rule 70 EPC)
4.1 First check box
The request for examination is not deemed to be
filed until the examination fee has been paid
(Article 94(1) and Rule 70(1) EPC). The box for
the request is pre-crossed in section 4.1 of
Form 1200.
Persons having their residence or principal place
of business in an EPC contracting state with an
official language other than English, French or
German, and nationals of that state who are
resident abroad, may file the request for
examination in an admissible non-EPO language
(Article 14(4) EPC), using the space provided.
4.1 Second check box
For applicants who file the request for
examination in an admissible non-EPO language
in addition to the (pre-crossed) request in the
language of the proceedings, the examination fee
is reduced by 30% provided they are an SME, a
natural person, a non-profit organisation, a
university or a public research organisation
(Rule 6(4) EPC, Article 14(1) RFees).
Under Rule 6(6) EPC, applicants wishing to
benefit from the fee reduction must declare that
they are an entity or natural person covered by
Rule 6(4) EPC. They must file this declaration at
the latest by the time of payment of the fee in
question, either by crossing this box or separately
(for this purpose, non-mandatory EPA/EPO/OEB
Form 1011 is available from the EPO website). If
there are multiple applicants, for the reduction to
apply each one must be an entity or a natural
person within the meaning of Rule 6(4) EPC and
entitled to file documents in an admissible non-
EPO language (Article 14(4), Rule 6(3) EPC). For
more details see Notice from the EPO dated
10 January 2014 concerning amended Rule 6
EPC and Article 14(1) RFees (OJ EPO, 2014,
A23).
The request for examination is available in all
admissible non-EPO languages on the EPO
website.
The request for examination (i.e. written request
plus payment of the examination fee) must be
filed either up to six months from the date on
which the international search report (or the
declaration under Article 17(2)(a) PCT) was
published (Article 153(6) EPC) or within
31 months from the filing date or, where
applicable, the (earliest) priority date, whichever
period ends later. In practice this means that the
request for examination must be submitted within
the 31-month period (Rule 159(1)(f) EPC), unless
the international search report was published late.
5. Additional copies of the documents cited in
the supplementary European search report
One or more additional sets of copies of the
documents cited in the supplementary European
search report (see Rule 65 EPC) can be ordered
against payment of the flat-rate fee(s).
6. Documents intended for proceedings before
the EPO (Rule 159(1)(b) EPC) and response to
the written opinion established by the EPO
(Rule 161(1) EPC)
When an application enters the European phase
applicants must specify the application
documents, as originally filed or as amended, on
EP
Annex EP.II, page 12 PCT Applicant’s Guide National Phase National Chapter – EP
(1 March 2018)
3
EPO 1200 Notes 03.18
which the European grant procedure is to be
based (Rule 159(1)(b) EPC). Section 6 allows
them to clarify whether they wish to proceed with
the published documents, whereby any
amended claims filed with the International
Bureau under Article 19 PCT replace the
originally filed claims, unless expressly stated
to the contrary in proceedings before the
EPO as designated Office without PCT
Chapter II (section 6.1), or
the documents on which the international
preliminary examination report is based in
proceedings before the EPO as elected Office
under PCT Chapter II (section 6.2).
Sections 6.1 and 6.2 also provide the possibility to
indicate that amended documents filed on entry
into the European phase are to form the basis for
the grant procedure.
For Euro-PCT applications where a
supplementary European search report will not be
prepared, the following applies (see Guidelines for
Examination in the EPO, E-IX, 3.2, for details):
Where the EPO has acted as the International
Searching Authority (ISA) and, if a demand under
Article 31 PCT was filed, also as the International
Preliminary Examining Authority (IPEA), or as the
Supplementary International Searching Authority
(SISA), the applicant will be required to respond
to any negative written opinion (WO-ISA)
prepared by the EPO as ISA, or, where
applicable, to the negative international
preliminary examination report (IPER) prepared
by the EPO as IPEA, or to the objections raised in
the explanations given in the Supplementary
International Search Report (SISR) under
Rule 45bis.7(e) PCT, as the case may be. The
time limit for response is six months from the
invitation under Rule 161(1) EPC (see OJ EPO
2010, 634). Failure to respond in due time will
lead to the application being deemed to be
withdrawn (Rule 161(1) EPC).
New amendments (Articles 28 and 41 PCT)
and/or comments which are filed on entry into the
regional phase before the EPO will be considered
to constitute a response to the WO-ISA, or to the
IPER or the explanations given in the SISR, as
the case may be, if the applicant indicates on
Form 1200 that such amendments and/or
comments are to form the basis for further
prosecution of the application. Similarly,
amendments under Article 19 and/or 34 PCT filed
in the international phase and maintained on entry
into the European phase by making the
appropriate entries on Form 1200 may constitute
a response, subject to certain requirements (see
Guidelines for Examination in the EPO, C-III, 2.2,
and E-IX, 3, for details).
The applicant must therefore clearly indicate the
documents which are to form the basis for further
prosecution of the application by crossing the
appropriate boxes in section 6.1 or 6.2 as
applicable.
In all cases, the applicant should specify in the
table on page 8 of Form 1200 the documents
which are to be used for the European phase and
therefore form the basis for calculation of any
additional fee. Any exceptional circumstances
which may need further explanation must be
clarified on an additional sheet.
The applicant can also amend the application at
any time within a non-extendable period of six
months from the communication (Forms 1226AA,
1226BB, 1226CC) under Rule 161(1) and (2)
EPC, which is issued shortly after effective entry
into the European phase.
Pages of amendments filed during the six-month
period under Rule 161 EPC are not taken into
account in the calculation of the additional fee as
part of the filing fee. Consequently, if
amendments are filed at this stage which reduce
the number of pages already paid for, no refund of
the additional fee will be made.
If application documents filed on entry into the
European phase contain handwritten
amendments, an invitation to remedy this
deficiency will be issued, and in case of non-
compliance the application will be refused (see
Notice from the EPO dated 8 November 2013
concerning application of Rules 49 and 50 EPC to
handwritten amendments, OJ EPO 2013, 603).
Whenever amendments are filed, the applicant
must identify them and indicate the basis for them
in the application as filed (Rule 137(4) EPC) (see
Guidelines for Examination in the EPO, E-VIX,
3.4, and H-III, 2.1 and 2.1.1). If he fails to do so,
the examining division may issue a
communication under Rule 137(4) EPC
requesting the correction of the deficiency within a
non-extendable period of one month. If he then
fails to reply within that period, the application will
be deemed to be withdrawn under Article 94(4)
EPC.
If the applicant has supplied test reports in
proceedings before the EPO as International
Preliminary Examining Authority, the EPO
assumes that it may also use them in the
European grant proceedings.
6.3 Copies of the search results (Rule 141(1) EPC)
For each of the previous applications whose
priority is claimed, a copy of the search results
produced by the authority with which the
application was filed (Rule 141(1) EPC) has to be
supplied. This obligation applies to European
patent applications and international applications
EP
PCT Applicant’s Guide National Phase National Chapter – EP Annex EP.II, page 13
(1 March 2018)
4
EPO 1200 Notes 03.18
filed on or after 1 January 2011 (see
OJ EPO 2010, 410, OJ EPO 2011, 64, and
OJ EPO 2013, 217).
This box is to be crossed only if the copies of the
documents are indeed supplied when filing the
form for entry into the European phase. If,
however, a copy of the search results is included
in the file by the EPO, no action is required on the
part of the applicant (see OJ EPO 2016, A19).
7. Translations
7.1 Translation of the international application
If the international application was not published
in an EPO official language, the applicant must
furnish the EPO with a translation of that
application in such a language within 31 months
of the filing date or, where applicable, the
(earliest) priority date.
The proceedings in the European phase will be
conducted in the language of the translation. The
translation must include the description, the
claims as originally filed, any text in the drawings,
and the abstract. It must also include any
indications under Rule 13bis.3 and 13bis.4 PCT in
the case of inventions relating to biological
material and any published request for
rectification (Rule 91.3(d) PCT).
7.2 Translation of the priority application
Under Rule 53(3) EPC, applicants may be invited
by the EPO to file a translation of the previous
(priority) application (see also OJ EPO 2013,
150).
Alternatively, they can submit a declaration under
Rule 53(3) that the European patent application is
a complete translation of the previous application.
They can do this by crossing the box in
section 7.3. In this case, no invitation to file a
translation of the priority application will be issued.
7.4 Claims amended under Article 19 PCT
If the applicant wishes the subsequent
proceedings to be based on the claims as
amended under Article 19 PCT, the translation
must also include those claims, together with any
explanatory statement (Rule 49.5(a)(ii), 49.5(c)
and (c-bis) PCT) and, in any event, the
accompanying letter under Rule 46.5(b) PCT.
7.5 Translation of annexes
Where PCT Chapter II applies, applicants must
prepare and file translations of all annexes to the
international preliminary examination report
(Article 36(2)(b) and (3)(b), Rule 70.16(a) PCT,
Rule 74.1 PCT), regardless of whether they are
seeking patent protection for the same version of
the application documents as was the subject of
that report.
8. Biological material
To enable the EPO to check compliance with
Rule 31 EPC, the receipt issued by the depositary
institution is to be submitted to the EPO.
Applicants are strongly advised to submit the
receipt when filing this form.
Waiver under Rule 33(1) and (2) EPC
Applicants may waive their right under Rule 33(1)
and (2) EPC to an undertaking from the requester
to issue a sample of the biological material,
provided that they are the depositor of the
biological material concerned. This waiver must
be expressly declared to the EPO in the form of a
separate, signed statement. It must specify the
biological material concerned (depositary
institution and accession number or depositor's
reference number as shown in the application
documents). It may be submitted at any time.
9. Nucleotide and amino acid sequences
9.1 If the application discloses one or more nucleotide
and/or amino acid sequences, a sequence listing
in electronic form complying with the
Administrative Instructions under the PCT (WIPO
Standard ST.25) is normally available to the EPO
as designated/elected Office if such sequence
listing was contained in the international
application in accordance with Rule 5.2(a) PCT,
furnished to the EPO as International Authority
under Rule 13ter.1(a) PCT, or otherwise made
available to it, e.g. by WIPO.
9.2 If the application discloses one or more nucleotide
and/or amino acid sequences and a sequence
listing in electronic form complying with the
Administrative Instructions under the PCT (WIPO
Standard ST.25) is not available to the EPO as
designated/elected Office, a standardised
electronic sequence listing must be filed on entry
into the European phase; otherwise, the EPO will
invite the applicant to file the sequence listing
(Rule 163(3) EPC). In this case, a late furnishing
fee is payable. For further information, see
Rules 163(3) and 30(3) EPC, as well as the
decision of the President of the EPO dated
28 April 2011 and the Notice from the EPO dated
18 October 2013 concerning the filing of
sequence listings (OJ EPO 2011, 372, and
OJ EPO 2013, 542).
If the standardised sequence listing is submitted
on entry into the European phase, the applicant
must declare that the subsequently filed sequence
listing does not include matter which goes beyond
the content of the application as originally filed.
The declaration can be made by crossing the
relevant box in section 9.2.
10. Designation of contracting states
All the contracting states designated in the
international patent application and party to the
EPC at the time of its filing are deemed to be
designated (see Article 79(1) EPC). Thus the EPC
EP
Annex EP.II, page 14 PCT Applicant’s Guide National Phase National Chapter – EP
(1 March 2018)
5
EPO 1200 Notes 03.18
contracting states that can be validly designated
on entry into the European phase are already
specified in the international phase
(Rule 4.9(a) PCT). For international applications
entering the regional phase on or after
1 April 2009, payment of the flat-rate designation
fee covers all the EPC contracting states, unless
individual designations are expressly withdrawn
(Article 2, item 3, RFees) (see OJ EPO 2009,
118).
11. Extension/validation
The application and the European patent granted
in respect of it are extended or validated, in
accordance with section 11 of Form 1200, to
those non-EPC contracting states designated for
a national patent in the international application
with which extension or validation agreements
were in force at the time of filing of the
international application.
The request for extension or validation for a state
is deemed withdrawn if the extension/validation
fee is not paid to the EPO within the time limit laid
down in the EPC for paying the designation fee
(Rule 159(1)(d) EPC) (see Guidelines for
Examination in the EPO, A-III, 12).
11.1 Extension of European patent applications and
the resulting European patents may be requested
for countries with which the EPO has extension
agreements (as at March 2018: Bosnia and
Herzegovina and Montenegro).
11.2 Validation of European patent applications and
the resulting European patents may be requested
for countries with which the EPO has validation
agreements (as at March 2018: Morocco, the
Republic of Moldova, Tunisia and Cambodia). The
EPO publishes the necessary information about
such agreements on its website and in its Official
Journal in good time before their entry into force.
12. Acceleration of procedure
The ways in which the European grant procedure
can be expedited in addition to the "PACE"
request are listed in the Notice from the EPO
dated 30 November 2015 (OJ EPO 2015, A94).
The options available on entry into the European
phase are gathered together in this section for
ease of selection.
12.1 Early processing
Request for the early start of processing in the
European phase ("early entry")
Applicants who wish the EPO as designated or
elected Office to start processing an application
before expiry of the 31-month time limit under
Rule 159(1) EPC must file an express request for
early processing. The request can be made by
crossing box 12.1.
A request for early processing is effective on the
date of its filing only if the requirements of
Rule 159(1) EPC applicable on that date have
been complied with. The nature of the
requirements to be met depends on the date on
which the request for early processing is filed (see
Notice from the EPO dated 21 February 2013
concerning the request for early processing,
OJ EPO 2013, 156, II.7 and 8).
Applicants must take note of the consequences
of an effective request for early processing (see
OJ EPO 2013, 156, III.9 and 10). Crossing box
12.1 must therefore be carefully considered.
An effective request for early processing
terminates the international phase in respect of
the EPO as designated/elected Office. This
means that the application will be processed
immediately as a European application as from
the date the request for early processing is
effective, and reversion to the 31-month time limit
is excluded. This implies, for instance, that the
time limits for filing the request for examination
and paying the examination fee, the designation
fee and the third renewal fee are those applying to
a European application, and are no longer
deferred to expiry of the 31-month time limit under
Rule 159(1) EPC.
The automatic debiting of all relevant fees is
available for requests for early processing filed on
or after 1 November 2017 (see Arrangements for
the automatic debiting procedure (AAD,
Annexes A.1 and A.2 to the ADA)). However,
automatic debiting can only be performed if the
documents referred to in Article 20 PCT are
available to the EPO, so that it can establish
whether or not a page fee for the 36th and each
subsequent page must be debited. These
documents are normally available to the EPO if
the international application has already been
published,
the EPO is the receiving Office, or
the EPO acts as (S)ISA or IPEA.
In all other cases, if they want the request to take
effect immediately, applicants must pay the
relevant fees due on filing the request for early
processing by a means of payment other than
automatic debiting. Otherwise the request will only
take effect on the day on which the EPO receives
the documents referred to in Article 20 PCT from
the IB in accordance with Rule 47.4 PCT.
EP
PCT Applicant’s Guide National Phase National Chapter – EP Annex EP.II, page 15
(1 March 2018)
6
EPO 1200 Notes 03.18
Applicants are recommended to read the
Notice from the EPO dated 21 February 2013
concerning the request for early processing
(OJ EPO 2013, 156). Further information is
available in the Guidelines for Examination in
the EPO, E-IX, 2.8, and the Euro-PCT Guide,
10th edition, 427-440.
12.2 Waivers
Waiver of communication pursuant to Rules 161
and 162 EPC
The time limit under Rules 161 and 162 EPC is
six months (see OJ EPO 2010, 634).
In order to accelerate the European grant
procedure applicants can, in addition to filing a
"PACE" request, expressly waive their right to
the communication under Rules 161(1) or (2)
and 162 EPC by crossing the first box in
section 12.2.
The EPO will not issue a communication under
Rules 161(1) or (2) and 162 EPC only if, in
addition to the "waiver", on entry into the
European phase the applicant has also fulfilled all
the requirements of Rules 161 and 162 EPC (i.e.
payment of any claims fees due and, where
required, submission of a response under
Rule 161(1) EPC) for the application to proceed
directly to the supplementary European search or
to examination. To accelerate the processing of
the application further, the applicant can request
accelerated search or examination under the
PACE programme (see Notice from the EPO
dated 30 November 2015 concerning the
programme for accelerated prosecution of
European patent applications ("PACE"), OJ EPO
2015, A93).
Where the right to the communication under
Rules 161(1) or (2) and 162 EPC has not been
validly waived, the communication will be issued
and the application will be processed only after
expiry of the six-month period provided for under
those rules, even if a request under the PACE
programme has been filed.
See also Notices from the EPO dated 5 April 2011
and 30 November 2015 (OJ EPO 2011, 354 and
OJ EPO 2015, A94).
Waiver of the invitation under Rule 70(2) EPC
Applicants who file the request for examination
before receiving the supplementary European
search report are asked by the EPO, after the
search report has been sent, to confirm within a
six-month period that they wish to proceed further
with the application (Rule 70(2) EPC). Where they
also have to respond to the search opinion, their
response is required within this same period
(Rule 70a(2) EPC). To accelerate the procedure,
they can waive their right to be asked for such
confirmation by crossing the second box in
section 12.2, in which case confirmation is
deemed to be given when the supplementary
European search report is transmitted to them.
With regard to the legal consequences, see
Guidelines for Examination in the EPO, C-VI, 3.
13. Payment
Fees due in respect of a patent application can be
paid in a number of different ways, i.e. by debiting
a deposit account, by credit card or by bank
transfer. For more information, see "Making
payments" on the EPO website.
Debiting a deposit account/automatic debiting
The procedure for paying by debiting a deposit
account or by automatic debiting is set out in
detail in the Arrangements for deposit accounts
(ADA), the Arrangements for the automatic
debiting procedure (AAD, Annex A.1 to the ADA)
and the Information from the EPO concerning the
automatic debiting procedure (Annex A.2 to the
ADA) published in the supplementary publication
to the EPO’s Official Journal.
Careful attention should be paid to the conditions
applicable to the filing of debit orders.
Payment by credit card
Payments by credit card must be made via the
EPO’s credit card fee payment service available
on the EPO website, using a credit card accepted
by the EPO (as at December 2017: Master Card
and VISA). The procedure is set out in detail in
the Notice from the European Patent Office
concerning the payment of fees by credit card
published in the EPO’s Official Journal.
Bank transfers
The procedure for paying by bank transfer is set
out in detail in the Notice from the European
Patent Office concerning fee payments via bank
transfer published in the EPO’s Official Journal.
Payments by bank transfer should be made to the
following account with the Commerzbank in
Germany:
Account No. 3 338 800 00 / Sort code 700 800 00
IBAN DE20 7008 0000 0333 8800 00
BIC DRESDEFF700
Commerzbank AG
Leopoldstrasse 230
80807 Munich
Germany
For fee information, see "Guidance for the
payment of fees, costs and prices", which is
published regularly in the EPO's Official Journal.
EP
Annex EP.II, page 16 PCT Applicant’s Guide National Phase National Chapter – EP
(1 March 2018)
7
EPO 1200 Notes 03.18
For the fee amounts, see the publication
"Schedule of fees and expenses" or the
"Interactive schedule of fees" available on the
EPO website "European (EPC) fees".
14. Refunds
Any refunds due to an applicant who has a
deposit account with the EPO may be credited to
that account. Applicants who wish this to be done
must indicate the account number and the
account holder’s name in this section. If the
account is held by a representative, refunds will
be made to him. Refunds will not be made to
third-party payers, except for the fee for file
inspection or at the express request of a party to
proceedings.
See also Guidelines for Examination in the EPO,
A-X, 10.4.
III. Table for section 6 of Form 1200.3
Documents intended for proceedings
before the EPO
The table is used for calculating the additional fee
for applications comprising more than 35 pages
(Article 2, item 1a, RFees). For further information
see the Euro-PCT Guide, part E-VII.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.I, page 1
(1 March 2018)
FEES
(Currency: Euro)F
1
Filing fee:
where the form for entry into the European phase (EPO Form 1200) is filed online ...... 120
where the form for entry into the European phase (EPO Form 1200) is not filed online ... 210
Additional fee for pages in excess of 35:
for the 36th and each subsequent page ............................................. 15
Additional fee in the case of a divisional application filed in respect of any earlier application
which is itself a divisional application
fee for a divisional application of second generation ............................. 210
fee for a divisional application of third generation ............................... 425
fee for a divisional application of fourth generation .............................. 635
fee for a divisional application of fifth or any subsequent generation ................. 850
Designation fee for one or more EPO Contracting States designated ....................... 585
Extension fee for each extension State (extension of the European patent to certain States
which are not EPO Contracting Statessee Summary) ................................ 102
Fee for validation of the European patent in:
Cambodia:
2
........................................................... 180
Morocco:
3
............................................................ 240
Republic of Moldova:
4
................................................... 200
Tunisia:
5
............................................................. 180
Claims fee:
for the 16th and each subsequent claim up to the limit of 50 ........................ 235
for the 51th and each subsequent claim ....................................... 585
Search fee in respect of a European or supplementary European search:
for international applications filed before 1 July 2005 ............................ 885
for international applications filed on or after 1 July 2005 ......................... 1,300
Fee for further processing:
in the event of late payment of a fee ................................... 50% of the relevant fee
in the event of late performance of the acts under Rule 71(3) EPC ................... 255
other cases ............................................................ 255
Fee for late furnishing of a sequence listing ......................................... 230
Examination fee:
for international applications filed before 1 July 2005 ........................ 1,825
for international applications filed on or after 1 July 2005 for which no supplementary
European search report is drawn up ................................... 1,825
for all other international applications filed on or after 1 July 2005 ................ 1,635
Renewal fees for European patent applications:1F2F2F
6
for the 3rd year counted from the international filing date ......................... 470
for the 4th year counted from the international filing date ......................... 585
for the 5th year counted from the international filing date ......................... 820
for the 6th year counted from the international filing date ......................... 1,050
for the 7th year counted from the international filing date ......................... 1,165
1
This list is based on the Schedule of fees and expenses of the European Patent Office. For the currently valid version of this
Schedule reference is made to the Guidance for the payment of fees and expenses, in the latest issue of the OJ EPO on to the EPO’s
website.
2
Validation of the European patent in Cambodia is only available for international applications filed on or after 1 March 2018.
3
Validation of the European patent in Morocco is only available for international applications filed on or after 1 March 2015.
4
Validation of the European patent in the Republic of Moldova is only available for international applications filed on or after
1 November 2015.
5
Validation of the European patent in Tunisia is only available for international applications filed on or after 1 December 2017.
6
The obligation to pay renewal fees to the EPO ceases with the payment of the renewal fee due in respect of the year during which
the grant of the European patent has been published in the European Patent Bulletin.
EP
Annex EP.I, page 2 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
for the 8th year counted from the international filing date ......................... 1,280
for the 9th year counted from the international filing date ......................... 1,395
for the 10th and each subsequent year counted from the international filing date ......... 1,575
Additional fee for late payment of a renewal fee ............................... 50% of the relevant fee
Fee for grant3F3F
7
, including fee for printing the European patent specification:
where the application documents to be printed comprise not more than 35 pages ........ 925
where the application documents to be printed comprise more than 35 pages ........... 925
plus for the 36th and each subsequent page .................................... 15
Fee for grant4F4F
8
, including fee for publication of the European patent specification ............. 925
Fee for reestablishment of rights/fee for requesting restoration/fee for reinstatement of rights .... 640
Fee for appeal .............................................................. 1,880
Extract from the Rules Relating to Fees
Article 5
Payment of fees
(1) The fees due to the Office shall be paid in euro by payment or transfer to a bank account held by the Office.
(2) The President of the Office may allow other methods of paying fees than those set out in paragraph 1.
Article 6
Particulars concerning payments
(1) Every payment must indicate the name of the person making the payment and must contain the necessary
particulars to enable the Office to establish immediately the purpose of the payment.
(2) If the purpose of the payment cannot immediately be established, the Office shall require the person making the
payment to notify it in writing of this purpose within such period as it may specify. If he does not comply with
this request in due time the payment shall be considered not to have been made.
Article 7
Date to be considered as the date on which payment is made
(1) The date on which any payment shall be considered to have been made to the Office shall be the date on which
the amount of the payment or of the transfer is actually entered in a bank account held by the Office.
(2) Where the President of the Office allows, in accordance with the provisions of Article 5, paragraph 2, other
methods of paying fees than those set out in Article 5, paragraph 1, he shall also lay down the date on which
such payments shall be considered to have been made.
(3) Where, under the provisions of paragraphs 1 and 2, payment of a fee is not considered to have been made until
after the expiry of the period in which it should have been made, it shall be considered that this period has been
observed if evidence is provided to the Office that the person who made the payment
(a) fulfilled one of the following conditions in a Contracting State within the period within which the payment
should have been made:
(i) he effected the payment through a banking establishment;
(ii) he duly gave an order to a banking establishment to transfer the amount of the payment and
(b) paid a surcharge of 10% on the relevant fee or fees, but not exceeding EUR 150; no surcharge is payable if a
condition according to sub-paragraph (a) has been fulfilled not later than ten days before the expiry of the
period for payment.
(4) The Office may request the person who made the payment to produce evidence as to the date on which a
condition according to paragraph 3(a) was fulfilled and, where required, pay the surcharge referred to in
paragraph 3(b), within a period to be specified by it. If he fails to comply with this request or if the evidence is
insufficient, or if the required surcharge is not paid in due time, the period for payment shall be considered not
to have been observed.
7
Applicable to international applications entering the regional phase before 1 April 2009.
8
Applicable to international applications entering the regional phase on or after 1 April 2009.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.I, page 3
(1 March 2018)
Article 8
Insufficiency of the amount paid
A time limit for payment shall in principle be deemed to have been observed only if the full amount of the fee has
been paid in due time. If the fee is not paid in full, the amount which has been paid shall be refunded after the period
for payment has expired. The Office may, however, in so far as this is possible within the time remaining before the
end of the period, give the person making the payment the opportunity to pay the amount lacking. It may also,
where this is considered justified, overlook any small amounts lacking without prejudice to the rights of the person
making the payment.
Article 9
Refund of search fees
(1) The search fee paid for a European or supplementary European search shall be fully refunded if the European
patent application is withdrawn or refused or deemed to be withdrawn at a time when the Office has not yet
begun to draw up the search report.
(2) Where the European search report is based on an earlier search report prepared by the Office on an application
whose priority is claimed or an earlier application within the meaning of Article 76 of the Convention or of
Rule 17 of the Convention, the Office shall refund to the applicant, in accordance with a decision of its
President, an amount which shall depend on the type of earlier search and the extent to which the Office
benefits from the earlier search report when carrying out the subsequent search.
Article 11
Refund of examination fee
The examination fee shall be refunded:
(a) in full if the European patent application is withdrawn, refused or deemed to be withdrawn before substantive
examination has begun;
(b) at a rate of 50% if the European patent application is withdrawn after substantive examination has begun and
before expiry of the time limit for replying to the first invitation under Article 94, paragraph 3, of the
Convention issued by the Examining Division proper or, if no such invitation has been issued by the Examining
Division, before the date of the communication under Rule 71, paragraph 3, of the Convention.
Article 14
Reduction of fees
(1) The reduction laid down in Rule 6, paragraph 3, of the Convention shall be 30% of the filing fee or examination
fee.
(2) Where the European Patent Office has drawn up an international preliminary examination report, the
examination fee shall be reduced by 50%. If the report was established on certain parts of the international
application in accordance with Article 34, paragraph 3(c), PCT, the fee shall not be reduced if subject-matter
not covered by the report is to be examined.
Extract from the Arrangements for deposit accounts which may be used for the settlement of
fees or the cost of publications and other services payable to the EPO2F5F5F
9
1. General provisions
Under Articles 5(2) and 7(2) of its Rules relating to Fees (RFees), the EPO makes available, for any interested
natural or legal person (or bodies equivalent to a legal person under the law applicable to them), deposit accounts for
paying fees, expenses and prices to the EPO. Deposit accounts are kept in euro only, at EPO headquarters in
Munich.
2. Formalities for opening and closing an account
2.1 A deposit account may be opened at the request of the prospective account holder. He must provide all the
necessary particulars about his person, occupation and address. This is done by completing and submitting the
online request form on the EPO website under Applying for a patent -> Forms and fees -> Making payments”.
If his contact details change, the account holder must inform the EPO accordingly, also using the online request
form.
9
Arrangements for deposit accounts (ADA) and their annexes (valid as from 1 December 2017): See Supplementary publication 5,
OJ EPO 2017.
EP
Annex EP.I, page 4 PCT Applicant’s Guide – National Phase National Chapter EP
(1 March 2018)
2.2 A deposit account may be closed at the signed written request of the deposit account holder or his successors
in title, filed by email attachment sent to support@epo.org, or by completing and submitting the online form
available on the EPO website under Applying for a patent -> Forms and fees -> Making payments together with
the signed written request. From the request it must be evident that the requester and the deposit account holder are
the same person.
Successors in title must provide the EPO with documentary proof of their entitlement.
2.5 A deposit account can be re-opened at the request of the original account holder, made by crossing the
appropriate box in the online request form referred to in point 2.1.
3. Replenishments, repayments and transfers between deposit accounts
3.1 Once the deposit account has been opened, its number is communicated to the holder, who must then make an
initial payment commensurate with his requirements and the intended frequency of replenishment, so as to ensure
that there are sufficient funds in the account.
3.2 Payments to replenish deposit accounts must be made into the EPOs bank account.
10
The payment must
include the following information in the reference field of the bank transfer: replenishment (or repl for short) or
deposit, followed by the eight-digit number (starting with 28) of the EPO deposit account concerned. They are
credited to the deposit account as of the date on which the payment is actually entered in the EPO bank account.
5. Debiting the account
Subject to point 8, deposit accounts may be debited only in respect of fees, expenses and prices payable to the EPO
in connection with European and PCT proceedings.
5.1. Types of debit orders and accepted means of filing
5.1.1 Debiting occurs only on the basis of an electronic debit order signed by the account holder or the authorised
representative. The signature may take the form of a text string signature, a facsimile signature, an enhanced
electronic signature,
11
or authentication with smart card if payment is made via Online Fee Payment in Online
services.
The debit order may be:
a debit order for individual fees for one or more applications, i.e. a single or a batch debit order, or
an automatic debit order
12
for a specific European or international patent application, authorising the EPO to
debit fees automatically as the proceedings progress.
5.1.2 The debit order must be filed in an electronically processable format (XML) via one of the following:
EPO Online Filing or the EPO Case Management System (CMS), using EPO Forms 1001E, 1200E, 2300E
or 1038E;
the EPO Online Filing software or PCT-SAFE, CMS and ePCT using the PCT fee calculation and payment
feature;
13
Online Fee Payment in Online services.
5.1.3 Debit orders submitted in any other way, e.g. on paper, by fax, via the web-form filing service or using a
different format such as a PDF attachment, are invalid and thus will not be carried out. The EPO will inform the
party to the proceedings accordingly, as a courtesy service. The legal consequence of filing an invalid debit order is
laid down in point 5.4.2.
5.4 Payment date
5.4.2 If a debit order is submitted via a non-accepted means of filing or in an invalid format, the date of receipt will
not be regarded as the payment date. If this means that a time limit for paying a fee has expired, the party to the
proceedings
14
may make use of any of the legal remedies available under the EPC or the PCT.
10
The following account with the Commerzbank in Germany is available for payments and transfers from all member states:
Nr. 3 338 800 00 (BLZ 700 800 00), IBAN DE20 7008 0000 0333 8800 00, BIC DRESDEFF700, Commerzbank AG,
Leopoldstrasse 230, 80807 München, Germany.
11
For further details, see the decision of the President dated 15 November 2015 concerning the electronic filing of documents
(OJ EPO 2015, A91).
12
See point 7 ADA, the Arrangements for automatic debiting (Annex A.1 in this supplementary publication) and information from
the EPO concerning the automatic debiting procedure (Annex A.2, loc. cit.).
13
The payment of all fees related to PCT proceedings at the EPO may be indicated via the online filing PCT-SFD plug-in.
14
A party to the proceedings may be e.g. an applicant, opponent, appellant or, if the party is represented, its international agent or
European representative.
EP
PCT Applicant’s Guide – National Phase National Chapter EP Annex EP.I, page 5
(1 March 2018)
5.5 Unavailability of the accepted electronic means of filing debit orders
If a payment period expires on a day on which one of the accepted means of filing debit orders under point 5.1.2 is
not available at the EPO, the payment period is extended to the first day thereafter on which all such means as are
available for the type of application concerned can be accessed again. In the event of a general unavailability of
electronic communication services, or if other like reasons within the meaning of Rule 134(5) EPC or
Rule 82quater.1 PCT arise, payment periods are extended in accordance with these provisions.
7. Automatic debiting procedure
Deposit account holders may have their accounts debited automatically on the basis of an automatic debit order. The
conditions applicable, and in particular the types of proceedings and fees covered, are laid down in the Arrangements
for the automatic debiting procedure (AAD).
15
Extract from the decision of the President of the European Patent Office concerning the
payment of fees by credit card
16
The President of the European Patent Office, having regard to Articles 5(2) and 7(2) of the Rules relating to Fees,
has decided as follows:
Article 1
Credit card as a method of fee payment
Fees due to the EPO may be paid by credit card under the conditions set forth in the present decision.
Article 2
Conditions for use
Payments by credit card must be made in euro via the EPOs credit card fee payment service, using a credit card
accepted by the EPO.
Article 3
Date of payment
Payment by credit card is deemed to have been made on the date on which the transaction is approved. This date is
indicated in the transaction confirmation made available to the payer.
Article 5
Entry into force
This decision enters into force on 1 December 2017.
15
See Annex A.1 in this supplementary publication. See also Annex A.2 in this supplementary publication for information from the
EPO concerning the automatic debiting procedure.
16
Decision of the President and Notice from the European Patent Office dated 22 August 2017 concerning the payment of fees by
credit card: See OJ EPO 2017, A72 and A73.
EP
PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.III, page 1
(1 April 2008)
In Sachen der oben bezeichneten europäischen Patentanmeldung nennt (nennen) der (die) Unterzeichnete(n)1 / In respect of the above European patent application
I (we), the undersigned1 / En ce qui concerne la demande de brevet européen susmentionnée, le(s) soussigné(s)1
als Er nder 2 : / do hereby designate as inventor(s)2: / désigne(nt) en tant qu’inventeur(s)2 :
Weitere Er nder sind auf einem gesonderten Blatt angegeben. / Additional inventors are indicated on a supplementary sheet. /
D'autres inventeurs sont mentionnés sur une feuille supplémentaire.
Der (Die) Anmelder hat (haben) das Recht auf das europäische Patent erlangt 3 / The applicant(s) has (have) acquired the right to the European patent3 /
Le(s) demandeur(s) a (ont) acquis le droit au brevet européen3
gemäß Vertrag vom / als Arbeitgeber / durch Erbfolge /
by an agreement dated / as employer(s) / as successor(s) in title /
en vertu du contrat passé le en qualité d’employeur(s) par succession
bitte wenden / P.T.O. / T.S.V.P.
Zeichen des Anmelders / Applicant’s reference /
Référence du demandeur
(max. 15 Positionen / max. 15 spaces / 15 caractères au maximum)
Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent être indiqués en caractères d‘imprimerie. S’il s’agit d’une personne morale, la position occupée
au sein de celle-ci par le ou les signataires doit également être indiquée en caractères d‘imprimerie.
Ort / Place / Lieu
(falls Anmelder nicht oder nicht allein der Er nder ist) /
(where the applicant is not the inventor or is not the sole inventor) /
(si le demandeur n’est pas l’inventeur ou l’unique inventeur)
Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): /
Signature(s) of applicant(s) or representative(s): /
Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :
Datum / Date
1
EPA/EPO/OEB 1002 12.07
Anmeldenummer oder, falls noch nicht bekannt, Bezeichnung der Er ndung: /
Application No. or, if not yet known, title of the invention: /
No de la demande ou, s‘il n’est pas encore connu, titre de l’invention :
Er ndernennung
Designation of inventor
Désignation de l’inventeur
EP
Annex EP.III, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP
(1 April 2008)
EPA/EPO/OEB 1002 12.07
Fußnoten zur Vorderseite
1 Name(n) des (der) Unterzeichneten nach
Maßgabe der Regel 41 (2) c) und d) EPÜ:
Bei natürlichen Personen ist der Familienname
vor den Vornamen anzugeben.
Bei juristischen Personen und Gesellschaften,
die juristischen Personen gemäß dem für sie
maß gebenden Recht gleich ge stellt sind, ist die
amtliche Bezeichnung anzugeben.
2 Name(n), Vorname(n) und vollständige
Anschrift(en) des Er nders (der Er nder)
gemäß Regel 19 (1) EPÜ.
3 Ist der Anmelder nicht oder nicht allein der
Er nder, so hat die Er ndernennung eine
Erklärung darüber zu enthalten, wie der An-
melder das Recht auf das euro päische Patent
erlangt hat (Artikel 81, Regel 19 (1) EPÜ).
Bei rechtsge schäft licher Übertragung genügt
die Angabe „gemäß Vertrag vom ...“.
Bei Arbeit nehmerer ndungen genügt der
Hinweis, dass der oder die Er nder Arbeit-
nehmer des Anmelders/der An melder ist bzw.
sind.
Bei Erbfolge genügt die Angabe, dass
der oder die Anmelder Erbe(n) des Er nders/
der Er nder ist bzw. sind.
Renvois concernant le texte  gurant
au recto
1 Nom(s) du (des) soussigné(s), conformément
à la règle 41(2)c) et d) CBE :
Les personnnes physiques doivent être désig-
nées par leurs noms suivis de leurs prénoms.
Les personnes morales et les sociétés assimi-
lées aux personnes morales en vertu du droit
dont elles relèvent doivent  gurer sous leur
désignation of cielle.
2 Nom(s), prénom(s) et adresse(s) complète(s)
de l’(des) inventeur(s), conformément à la
règle 19(1) CBE.
3 Si le demandeur n’est pas l’inventeur, ou
l’unique inventeur, la désignation de l’inventeur
doit comporter une déclara tion indiquant
l’origine de l’acquisition du droit au brevet
euroen (article 81 et règle 19(1) CBE).
En cas de transfert contractuel, il suf t de
mentionner « en vertu du contrat
passé le ... ».
Pour les inventions de salars, il suf t
d‘indiquer que le ou les inventeurs sont des
employés du ou des demandeurs.
En cas de transfert successoral, il suf t
d’indiquer que le ou les demandeurs sont les
héritiers du ou des inventeurs.
Footnotes to text overleaf
1 Name(s) of the undersigned in accordance
with Rule 41(2)(c) and (d) EPC:
Names of natural persons shall be indicated
by the person’s family name, followed by his
given names.
Names of legal persons, and of bodies equi-
valent to legal persons under the relevant law,
shall be indicated by their of cial designations.
2 Family name(s), given name(s) and full
address(es) of the inventor(s) in accordance
with Rule 19(1) EPC.
3 If the applicant is not the inventor or is not the
sole inventor, the designation shall contain a
statement indicating the origin of the right to
the European patent (Article 81, Rule 19(1)
EPC).
In the case of assignment the words
”by agreement dated ...” suf ce.
In the case of inventions by employees a
mention that the inventor(s) is/are employee(s)
of the applicant(s) is suf cient.
In the case of succession a mention that the
applicant(s) is/are heir(s) of the inventor(s) is
suf cient.
EP
PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.IV, page 1
(30 May 2013)



 
 


  

 
  











 
 

 


 
 

 










9ROOPDFKW
$XWKRULVDWLRQ
3RXYRLU



111



 

EP
Annex EP.IV, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP
(30 May 2013)
, )XQRWHQ]XU9RUGHUVHLWH
  







  


  






  





 
 















 


 
 

 

 
 









 








,, +LQZHLVH
 



 






 



 


,  5HQYRLVFRQFHUQDQWOHWH[WH
¿JXUDQWDXUHFWR
  























 
 







 






 


 


 

 










 







,,1RWHV
 



 





 



 



, )RRWQRWHVWRWH[WRYHUOHDI
  

  



  
  
  

  


  







  
  
  
 
 












 
 
 


 

 

 


















,,1RWLFHV
 


  
 




 




 


11.11
EP
PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.V, page 1
(30 May 2013)
1
General authorisation
EPO 1004 09.11
I (We)
Full name and address of authorisor(s)
Please forward the original direct to the EPO,
Legal Division (Dir. 5.2.3) in Munich.
Please read the attached notes before
completing the form.
General
authorisation No.

1
2
3
4
5
6
7
 
Place, Date Signature*
do hereby authorise
Full name and address
of authorisee: professional
representative, legal practitioner,

representatives – please specify
to represent me (us) in all proceedings established by the European Patent Convention and to act for me (us) in all patent
transactions.

!"
#$!
%
!
* The form must bear the personal signature(s) of the authorisor(s). In the case of legal persons, the signature
 !&!
EP
Annex EP.V, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP
(30 May 2013)
EPO 1004 09.11
Notes
to the General authorisation Form (EPO 1004)
The use of this form is recommended when authorising repre sen-
'*'*+professional
representatives and legal practitioners under Article 134(8)
'"/employees%6777'"
associations of representatives;6<=66'"%
%6777'"!!
has been issued up to the present time. If the authorisee is an
!
practitioner, the authorisor must make a declaration in the general
authorisation or in a covering letter that the authorisee is his

!!
(hereafter “authorisor”) and the state in which their residence or
principal place of business is located must be given, in accordance
;>6=+
?@
!!
as well as of bodies equivalent to legal persons under the law
!!!
Addresses shall be indicated in accordance with applicable
B
comprise all the relevant administrative units, including the house
C
H!!
relevant information regarding the additional authorisors must be
!
Where there are several authorisors, a general authorisation can

If one of several authorisors cancels a general authorisation,
it remains valid for the other authorisors under the old registration
B!
registered.
The name(s) and address of the place of business of the
authorisee(s) must be given in accordance with Rule 41(2)(c)
=
!
of representatives. As regards the authorisation of an association
!;6<=66'"
the name and the number of the association must be given.
If there is more than one authorisee, please insert in the
address box the name and address of the place of business of
the authorisee to whom the EPO is to send a copy of the form
bearing the general authorisation number.
A communication regarding the registration of the general
authorisation is not !
for which the authorisee is or is to be appointed as representative.
J
authorisations in a general authorisation. When a general
authorisation is intended to supersede an earlier one, the earlier
@
The general authorisation of one or more authorisees terminates
as soon as the authorisor or the authorisee concerned –
not another authorisee – has communicated the termination to
the EPO in Munich (Directorate 5.2.3). The communication
!&
new general authorisation omitting the name of the authorisee
;6<=KQ'"
The powers
"!!$
!!!

!
'"!!
sub-authorisations%6777;6<='"
be it
(a) a  (Rule 152(2), second sentence,
 '"
(b) a general sub-authorisation;6<=>'"
When issuing a general sub-authorisation, Form EPO 1004 can for
$!
authorisation number from which he derives his power. When it is
registered, the general sub-authorisation keeps the same number
!!
#U
general sub-authorisation does not terminate vis-à-vis the EPO
!;6<=V'"
upon the termination of the authorisation given to the sub-authorisor

'*!
>
&'*
(see 3 above).
Where the authorisation is signed on behalf of a legal person,
only such persons as are entitled to sign by law and/or in
accordance with the articles of association or equivalent of
the legal person may do so %<Q'"
%!!@!
!/XYZ
J[!$Y!/\\
&!!
!

An authorisation bearing the
signature of a person not entitled to sign will be treated as an
unsigned authorisation.
1
2
3
4
5
6
7

Navigation menu